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ABSTRACT 
 
KIF1C is a kinesin-3 family motor protein that accumulates at the tip of the tail 
in migrating cells and transports α5β1-integrins into cellular protrusions and is 
therefore required for the regulation of cell adhesion structures. KIF1C also 
transports dense core vesicles (DCVs) in neurons. Consistent with its function 
in long distance transport, mutations in KIF1C causes hereditary spastic 
paraplegia (HSP) and cerebellar dysfunction in humans. Previous data 
generated in the Straube lab (Bachmann et al, unpublished) show that 
PTPN21, a scaffolding phosphatase restores KIF1C mediated α5-integrin 
transport when overexpressed in KIF1C-depleted cells. In this study, the 
hydrodynamic analysis of recombinant full-length KIF1C and crosslinking 
mass spectrometry reveals that KIF1C is a stable dimer that adopts an 
autoinhibited conformation by interaction of its tail with the motor domain. 
Next, we show that KIF1C is a processive plus-end directed motor in single 
molecule assays and confirm that the scaffold phosphatase PTPN21 is a 
positive regulator of KIF1C-mediated transport. We also investigate the 
structural domains of KIF1C contributing to the rear accumulation in cells and 
show that the proline rich domain at the C-terminus of KIF1C is required for 
the tail localisation of KIF1C, but that the binding of 14-3-3 proteins to the tail 
domain negatively regulates KIF1C. Finally, using optical trapping we show 
that a single KIF1C can generate forces up to 5.5 pN and the HSP-causing 
mutations are processive but weak motors. 
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CHAPTER 1 INTRODUCTION 
 
1.1. Cytoskeleton and Intracellular transport 
The cytoskeleton is the supporting structure of the cell that provides shape 
as well as spatial organization to carry out fundamental functions. The 
cytoskeletal system is comprised of microtubules, actin microfilaments and 
intermediate filaments. Microtubules are polymers of alpha and beta tubulin 
heterodimers (Luduena and Woodward, 1975). They have a growing plus end 
which extends to the periphery of a cell whereas most of the minus ends are 
anchored at the Microtubule organizing centre (MTOC). Microfilaments are 
polar, tightly packed polymers of filamentous actin (F-actin). Actin 
microfilaments are predominantly present in the edges of the cell and they 
contribute to cell motility (Carlier and Pantaloni, 2007). Microtubules and actin 
microfilaments act as tracks for intracellular transport driven by molecular 
motors. Kinesins and dynein drive transport along microtubules, whereas 
myosins drive actin based transport. Intermediate filaments are formed of 
multiple types of related monomer units and they are called so since their 
mean diameter (~10 nm) lies in between that of actin microfilaments (~8 nm) 
and microtubules (~25 nm). Intermediate filaments have higher tensile 
strength than microtubules and protect the cell from shearing stresses and 
opposing forces (Herrmann et al., 2007). Together, these three components 
of the cytoskeleton contribute towards the maintenance of cell structure and 
help perform vital functions. 
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Figure 1.1: Cytoskeletal filaments 
The three major classes of cytoskeletal filaments are depicted. (a) Microtubules, 
composed of alpha (light grey) and beta tubulin (dark grey) subunits. (b) Actin 
microfilaments, composed of G-actin monomers. (c) Intermediate filaments, 
composed of various monomer units. Adapted from (Insall and Machesky, 2001). 
 
1.2. Microtubule based transport 
Figure 1.2: Microtubule based cellular transport in a migrating cell 
Cytoskeleton network in a migrating cell. Motors transport cargo directionally along 
microtubules. Kinesins walk to the plus-ends and dynein to the minus-end of the 
microtubules. Adapted from (Bachmann and Straube, 2015). 
 
Microtubules carry out a range of functions such as supporting the cell 
shape, providing intracellular tracks for the translocation of cargo, and in 
participating in cell division and cell migration (Vicente-Manzanares et al., 
2005). These diverse functions are mediated by Microtubule-associated 
proteins (MAPs) (Etienne-Manneville, 2010) and post-translational 
modifications on alpha and beta tubulin sub units (Janke, 2014). Molecular 
motors are a class of MAPs that directionally transport cargo along 
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microtubule tracks. Dynein and kinesin are examples for molecular motors 
(Hirokawa, 1998) (Figure 1.2). 
Kinesin motors are present in all eukaryotes and are crucial for cell 
functionality since they transport intracellular cargo such as chromosomes, 
mitochondria (Nangaku et al., 1994) and secretory vesicles (Lo et al., 2011). 
They utilize ATP to generate mechanical force and step along microtubules 
(Cross, 2016). Kinesins have been classified into 15 families based on the 
sequence homology and position of their motor domain (Lawrence et al., 2004, 
Wickstead et al., 2010). In general, N-kinesins have the motor domain at the 
amino terminal and walk towards the plus-end of the microtubule, C-kinesins 
possess the motor domain to the carboxy end and walk to the minus-end 
whereas the M-kinesins have the motor domain in the middle and they 
destabilize microtubules (Bringmann et al., 2004) (Hirokawa et al., 2009). 
However, there are a few exceptions such as Cin8, Cut7 and KlpA. Kinesin-5 
motor protein Cin8 and Cut7 have a N-terminal motor domain but can walk bi-
directionally (Gerson-Gurwitz et al., 2011, Roostalu et al., 2011, Britto et al., 
2016). Whereas kinesin-14 motor protein KlpA which possesses a C-terminal 
motor domain has been reported to walk along the plus end-directed 
microtubules (Popchock et al., 2017). Members of the kinesin- 1, 2 and 3 
families have emerged to be vital in shuttling cargo in cells (Lipka et al., 2016, 
Elluru et al., 1995, Scholey, 2013). In particular, for kinesin -3 family motors, it 
is becoming clear that their main function is the long-distance transport of 
membranous cargo since they are highly processive, i.e. the distance they 
walk before falling off the microtubule track. This makes them particularly 
suited for long-haul tasks and their implication in neuronal diseases (Reid et 
al., 2002, Dor et al., 2014, Caballero Oteyza et al., 2014) has led to the need 
to understand the mechanism of motor activity and regulation. 
 
1.3. Kinesin-3 family 
UNC-104 was the first member of the kinesin-3 family to be identified in 
Caenorhabditis elegans as a result of the mutation affecting the transport of 
synaptic vesicles to the axon terminal (Hall and Hedgecock, 1991, Tsunetoshi 
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et al., 1991), following which other kinesins from different species were 
established based on homology to the motor domain of the UNC-104 (Miki et 
al., 2005). The kinesin-3 family comprises of six subfamilies in mammals KIF1, 
KIF13, KIF14, KIF16, KIF28 and a fungal-specific group of short kinesin-3-like 
proteins (Fuchs, 2004) (Figure 1.3), making it one of the largest kinesin super 
families (Miki et al., 2005). The mammalian kinesin-3 motors have been 
reported to be involved in a wide array of cellular functions. KIF1A (CeUNC-
104 homolog in mammals) is involved in transport of vesicles (Lo et al., 2011, 
Okada et al., 1995) and viral particles (Kratchmarov et al., 2013), KIF1B 
transports mitochondria (Nangaku et al., 1994), KIF1C is involved in neuronal 
transport, integrin transport and cell migration (Theisen et al., 2012, Kopp et 
al., 2006, Lipka et al., 2016), KIF14 in cytokinesis (Gruneberg et al., 2006, Xu 
et al., 2014) and in Rap1a-Radil signalling during breast cancer progression 
(Ahmed et al., 2012) , KIF13A and KIF16A in mitosis (Sagona et al., 2010, 
Torres et al., 2011), and KIF16B for early embryonic development (Ueno et 
al., 2011). 
Figure 1.3: Kinesin-3 family tree. 
Phylogenetic tree of selected kinesin-3 family members. Homo sapiens (Hs), 
Caenorhabditis elegans (Ce), Aspergillus nidulans (An), Neurospora crassa (Nc), 
Rattus norvegicus (Rn), Gibberella moniliformis (Gm), and Cochliobolus 
heterostrophus (Ch). Bold font indicates subfamilies. Human KIF5A, a kinesin 1, was 
used as root. Adapted from (Siddiqui and Straube, 2017). 
 
1.3.1. Kinesin-3 family - Cellular function and human disease 
 Kinesin-3-mediated transport is required for neuronal morphogenesis 
and function; mutations in any of the KIF1 motors KIF1A, KIF1B or KIF1C 
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cause neurological disorders, spastic paraplegia or multiple sclerosis both in 
human patients and mouse models (Dor et al., 2014, Yonekawa et al., 1998, 
Niwa et al., 2008, Caballero Oteyza et al., 2014, Aulchenko et al., 2008). C. 
elegans worms require axonal transport by UNC-104 for the coordination of 
their movement (Tsunetoshi et al., 1991). In addition, kinesin-3 motors have 
been shown to regulate signalling processes and the orderly progression of 
cell division. For example, KIF16A tethers the pericentriolar material to the 
daughter centriole during mitosis thereby preventing PCM fragmentation and 
enabling the formation of a bipolar mitotic spindle (Torres et al., 2011); and 
KIF13A translocates a component of the cell abscission machinery to the 
spindle midzone thereby controlling cytokinesis (Sagona et al., 2010). 
Likewise, deletion of the sole kinesin-3 in Ustilago maydis results in a cell 
separation defect (Wedlich-Soldner, 2002). Important cargoes of kinesin-3 
proteins are summarised in Table 1 and range from mitochondria and viruses 
to vesicles containing a variety of receptors, pre-synaptic signalling proteins, 
microtubule regulators and phospholipids (Okada et al., 1995, Drerup et al., 
2016, Fehling et al., 2013, Theisen et al., 2012, Horiguchi et al., 2006, Lo et 
al., 2011, Nangaku et al., 1994, Ueno et al., 2011). 
Motor Cargo Cell type Reference 
KIF1A Tyrosine kinase A receptor 
(TrkA) 
Mouse dorsal root 
ganglion neurons 
(Tanaka et al., 2016) 
 Synaptotagmin and 
synaptophysin 
Rat spinal nerves (cauda 
equina) 
(Okada et al., 1995) 
 Dense core vesicles Rat primary hippocampal 
neurons 
(Lo et al., 2011) 
 Beta secretase-1 Mouse SCG neurons (Hung and Coleman, 
2016) 
 AMPA receptors Rat brain (Shin et al., 2003) 
KIF1B mitochondria Mouse Neuro2a cells (Nangaku et al., 
1994) 
 SCG10 / Stathmin-2 Sensory axons in 
zebrafish 
(Drerup et al., 2016) 
 lysosomes Cos7 African green 
monkey fibroblast cells 
(Matsushita et al., 
2004) 
KIF1C a5b1-integrin 
 
Dense core vesicles 
RPE1 human epithelial 
cell line 
Rat primary hippocampal 
neurons 
(Theisen et al., 2012) 
 
(Lipka et al., 2016) 
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Table 1: Kinesin-3 cargoes. 
List of cargoes identified to be transported by selected kinesin-3 family members. 
 
1.3.2. Structure of kinesin-3 motors 
Figure 1.4: Primary structure of kinesin-3 family 
Schematic representation of the different kinesin-3 family members and their 
structural domain organization is depicted here. Blue-motor domain, green-coiled 
coil, red-FHA domain, pink-pleckstrin homology, orange-proline-rich, yellow-CAP-
Gly, purple-START domain. 
KIF13A Serotonin type 1A receptor Mouse hippocampal 
neurons 
(Zhou et al., 2013) 
 Viral matrix proteins Huh7 human hepatoma 
cell line 
(Fehling et al., 2013) 
 Mannose-6-phosphate 
receptors  
MDCK canine epithelial 
cell line 
(Nakagawa et al., 
2000) 
 FYVE-CENT HeLa human cervical 
cancer cell line 
(Sagona et al., 2010) 
KIF13B Human discs large (hDlg) 
tumour suppressor 
In vitro reconstitution with 
purified human KIF13B  
(Yamada et al., 2007) 
 PtdIns(3,4,5)P3-containing 
vesicles 
Rat PC12 cells and in vitro 
reconstitution 
(Horiguchi et al., 
2006) 
 Vascular endothelial 
growth factor receptor 2  
Human umbilical vein 
endothelial cells 
(HUVECs) 
(Yamada et al., 2014) 
 Transient receptor potential 
vanilloid 1 
CHO cells, rat dorsal root 
ganglion neurons 
(Xing et al., 2012) 
KIF16B Fibroblast growth factor 
receptor 
Mouse embryonic stem 
cells  
(Ueno et al., 2011) 
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All kinesin motors that walk towards the plus end of microtubules have their 
motor domain at the N-terminus of the molecule. This is also true for kinesin-
3 family motors. What sets kinesin-3 motors apart from other kinesins is the 
organisation of the neck region, which contains a b-strand as well as a helix 
(Miki et al., 2005), and the presence of a forkhead-associated (FHA) domain 
(Westerholm-Parvinen et al., 2000) in the tail. In addition to the FHA domain, 
the tail region contains a number of short coiled-coils and diverse protein and 
lipid interaction domains that mediate binding to cargo and regulators. 
The motor domain binds to the microtubule and the energy from ATP 
hydrolysis is used to produce directional movement (Endow, 1999, Vale et al., 
2000). A characteristic feature of the kinesin-3 family is the presence of a 
stretch of positively charged lysine residues designated as the K-loop in loop 
12 of the motor domain. This loop is ideally positioned so that it can make 
contact with the negatively charged glutamate-rich (E-hook) C-terminal tail of 
b-tubulin. The K-loop was proposed to enable processive motion of 
monomeric KIF1A by mediating diffusive interaction to microtubules 
throughout the ATPase cycle (Okada and Hirokawa, 1999, Okada and 
Hirokawa, 2000). However, reports suggest that the K-loop in KIF1, KIF13 and 
KIF16 increase microtubule affinity (Soppina and Verhey, 2014, Rogers et al., 
2001, Matsushita et al., 2009). An increase in processivity could not be 
attributed to the K-loop where these motors are working as dimers since the 
mutation of K-loop leads to decreased microtubule affinity but the processivity 
of motor remains unaffected (Soppina and Verhey, 2014). Instead, the K-loop 
promotes microtubule-binding and enables kinesin-3 motors to effectively 
work in teams (Rogers et al., 2001, Soppina and Verhey, 2014). Recent 
comparative high-resolution cryo electron microscopy structures of kinesin-1 
(KIF5A) and kinesin-3 (KIF1A) motor domains bound to microtubules in 
different nucleotide states paired with molecular dynamics simulations, 
ascertained which family-specific residue changes result in the 200-fold 
increased affinity of kinesin-3 motors to microtubules relative to kinesin-1 
(Scarabelli et al., 2015, Atherton et al., 2014). These residues reside in loops 
L2, L7, L8, L11, L12 and a-helices a4 and a6. Thus, the contribution of 
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multiple sites increases kinesin-3’s interaction surface with microtubules and 
results in a large effect on affinity. This increased affinity then increases the 
processivity of dimeric kinesin-3 motors (Atherton et al., 2014). Key residues 
that result in a 10-fold increased processivity of kinesin-3 versus kinesin-1 are 
Arg167 in loop 8, Lys266 in loop 11 and Arg346 in a-helix 6 of KIF1A 
(Scarabelli et al., 2015). 
Coiled coils are important structural features that mediate motor dimerisation 
(Peckham, 2011). Kinesin-3 motors tend not to contain the extended coiled 
coils that are typical for the tails of other kinesins, but instead contain a number 
of smaller predicted coiled-coil regions scattered along the tail. It is presently 
unclear whether all of these contribute to dimer formation. So far, the only 
direct test of this was performed with the fourth coiled-coil domain of KIF1C, 
which is sufficient to drive dimerisation in a yeast-two-hybrid assay (Dorner et 
al., 1999). In KIF1A, KIF13A and KIF13B, the coiled-coil domains seem to 
interfere with dimerisation. It has been shown that instead, the neck coil alone 
efficiently dimerises these motors (Hammond et al., 2009, Soppina et al., 
2014). 
FHA domains are small protein modules that recognise phospho-threonine 
epitopes on proteins and mediate protein-protein interactions (Li et al., 2000, 
Hammet et al., 2003). FHA domains have been found in more than 200 
different proteins with diverse cellular functions such as transcription, DNA 
repair and protein degradation (Durocher and Jackson, 2002). Besides 
fulfilling a structural role in kinesin-3 proteins, the FHA domain also confers 
specific cargo interactions. For example, the FHA domain of KIF13B 
medicates binding to its cargo transient receptor potential vanilloid 1 (TRPV1). 
Interestingly, this interaction depends on phosphorylation of KIF13B at T506 
in the FHA domain by cyclin-dependent kinase 5 (Cdk-5). (Xing et al., 2012). 
A point mutation that is likely to alter the folding of the FHA domain of KIF1C 
has been reported to change the anthrax susceptibility in mice. Ectopic 
expression of a resistant allele of KIF1C was shown to partially rescue anthrax 
susceptible macrophages (Durocher and Jackson, 2002, Watters et al., 2001) 
suggesting the importance of FHA domain, however more recently in vitro 
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assays with macrophages and in vivo assays in mice rule out kif1c gene as a 
candidate for anthrax toxin susceptibility (Nakajima and Tanaka, 2010). The 
role of the point mutation in the FHA domain remains unclear. 
Several kinesin-3 tails contain domains that allow direct interaction with 
membranes: e.g. KIF16A contains a START/lipid sterol-binding domain at the 
C-terminus (Torres et al., 2011). KIF1A and KIF1B have a pleckstrin homology 
(PH) domain that is important for binding cargo vesicles (Xue et al., 2010), 
probably through specific interaction with phosphatidylinositol 4,5-
bisphosphate (PtdIns(4,5)-P2) (Klopfenstein et al., 2002). KIF16B possesses 
a phosphoinositide-binding structural domain (PX), which binds to 
PtdIns(3,4,5)P3 and is involved in the trafficking of early endosomes (Blatner 
et al., 2007, Hoepfner et al., 2005). 
Other kinesin-3 tails contain protein interaction domains, such as a CAP-Gly 
domain at the C-terminus of KIF13B. CAP-Gly domains bind to sequence 
motifs at the C-terminus of tubulin and EBs, zinc-finger motifs and proline rich 
sequences (Steinmetz and Akhmanova, 2008). KIF1C possesses a proline-
rich region at the C-terminus. Proline-rich regions play a structural role and 
also act as binding sites for protein interaction (Williamson, 1994). In the case 
of KIF1C, this domain mediates several protein interactions, including the 
cargo adapter protein BICDR1, 14-3-3 proteins and Rab6 (Schlager et al., 
2010, Dorner et al., 1999, Lee et al., 2015). 
Surprisingly, a monomeric motor construct of KIF1A has been observed to 
undergo processive plus-end directed movement along microtubules (Okada 
and Hirokawa, 1999). This is thought to be possible due to the presence of the 
K-loop and a stable microtubule interaction surface that persists throughout 
the ATPase cycle (Atherton et al., 2014, Okada and Hirokawa, 2000). 
However, monomeric KIF1A only moves very slowly (0.15 µm/s) and weakly 
(~0.15 pN) along microtubules, while multiple KIF1A motors transport cargo at 
1.5 µm/s (Okada et al., 2003, Okada et al., 1995). Teams of 10 monomeric 
KIF1A motors have been proposed to become approximately 100-fold 
stronger than a single monomeric motor (Oriola and Casademunt, 2013), 
however, experimental data on the force generation of kinesin-3 teams are 
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lacking. There is evidence suggesting that kinesin-3 motors exist as inactive 
monomers in cells until activated by dimerisation (Soppina et al., 2014, Al-
Bassam et al., 2003, Rashid et al., 2005, Tomishige et al., 2002). Other studies 
suggest that KIF1A motors are dimeric in vivo, but in an autoinhibited state 
until activated by cargo binding (Hammond et al., 2009, Pollock et al., 1999). 
Thus, the extent to which individual kinesin-3 family members exist as 
monomers or dimers in cells remains to be elucidated. However, it is clear that 
a single monomeric motor cannot achieve the high processivity of kinesin-3 
mediated cargo transport observed in cells. Thus these would need either to 
work in teams formed by recruitment of several monomeric motors to the same 
cargo, or to form dimers. 
 
1.3.3. Regulation of Cargo Transport 
1.3.3.a. Mechanism of autoinhibition 
 
Figure 1.5: Models of Autoinhibition 
The two known models for autoinhibition are depicted here. A monomer to dimer 
switch model, where the motor is a diffusive monomer and is activated by dimerization 
and the autoinhibited dimer activated by cargo and/or adapter binding. 
 
Early work and biochemical characterisation of conventional kinesin 
revealed that the molecule exists in two conformations: a folded inactive 
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conformation and an extended active one (Hirokawa et al., 1989, Hackney et 
al., 1992). Consistent with an autoinhibited state, a small peptide region in the 
tail of kinesin-1 binds to the motor domain to inhibit it (Friedman and Vale, 
1999, Stock et al., 1999, Coy et al., 1999). Crystal structure of kinesin-1 
dimeric motor heads reveals a “double lockdown” mechanism where the 
movement of the motor heads is restricted due to the cross-linking at the coiled 
coil region and tail domains  (Kaan et al., 2011). While kinesin-3 motors do not 
contain such an extensive coiled-coil region with a hinge that allows neat 
folding and unfolding of the tail, inactive kinesin-3 motors have been shown to 
adopt a compact conformation with a crumpled tail (Hirokawa and Noda, 
2008), which is likely to extend when activated and/or under load. That the 
pool of motors exists in an autoinhibited state in cells is important because in 
the absence of cargo, motor activity needs to be tightly regulated to avoid 
microtubule crowding and futile ATP consumption. 
Currently, there are two models of autoinhibition that apply to kinesin-3 motors. 
In the monomer-dimer switch model, intramolecular interactions involving 
neck and tail regions hold some kinesin-3 motors in a monomeric, inactive 
state. Upon activation, these motors dimerise with their neck coil and tail 
regions undergoing intermolecular interactions. In the alternative tail block 
model, the motors are stable dimers, but regions of the tail interact with the 
motor or neck domains and interfere with motor activity until cargo binding 
occupies the tail region and releases the motor. Evidence exists for both 
models and the picture emerging is that different kinesin-3 motors might use 
either or a combination of both of these methods of autoinhibition. 
Most KIF1 and KIF13 motors are thought to undergo a monomer-dimer switch. 
Consistently with an autoinhibited state, full length UNC-104 from C. elegans 
and murine KIF1A are inactive in motility assays (Hammond et al., 2009, 
Okada et al., 1995). As a monomeric motor domain construct of KIF1A could 
produce some directional motion by itself and work as a processive motor 
when dimerised artificially (Okada and Hirokawa, 1999, Tomishige et al., 
2002), regions of the neck or tail interfere with motor activity. Indeed, in UNC-
104, the two neck helices can form an intramolecular coiled-coil, thereby 
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inhibiting the ATPase and microtubule binding cycle of the motor and holding 
the motor in a monomeric state (Al-Bassam et al., 2003). The neck helices can 
also form an intermolecular coiled-coil thereby enabling the switch from 
monomer to dimer, which is required to obtain a processive UNC-104 motor 
(Al-Bassam et al., 2003). In murine KIF1A, a similar switch through intra- and 
intermolecular coiled-coil formation is proposed to occur between the neck coil 
region and the first coiled coil domain (CC1). Surprisingly, the truncation of the 
entire tail results in processive dimeric motors of KIF1A, KIF13A and KIF13B, 
while all longer constructs containing CC1 result in monomers that only show 
diffusive movement, suggesting that the CC1 makes contacts with the neck 
region to keep the motors in a monomeric state (Hammond et al., 2009, 
Soppina et al., 2014). If autoinhibition is prevented by deletion of the flexible 
hinge between the neck helices in C. elegans UNC-104, the motility of the 
motor in vitro is unperturbed, but transgenic worms show severe defects in the 
coordination of their movement (Al-Bassam et al., 2003). Likewise, mutations 
in the CC1 segment of KIF1A result in activation of the motor (Huo et al., 2012, 
Yue et al., 2013). In the KIF13 subfamily, a proline residue at the junction of 
neck coil and CC1 provides the flexibility to enable CC1 to fold back and 
interact with the neck coil. Deletion of this proline residue results in 
dimerisation via the neck coil domains and active, processive motors (Soppina 
et al., 2014, Ren et al., 2016). Control of the autoinhibited state of the KIF1A 
motor might also involve the FHA domain and the following coiled coil CC2. A 
tandem construct of CC1 and FHA domains forms a very stable dimer. 
Furthermore, the dimerisation of CC1-FHA sequesters the CC1 region and 
makes it unavailable for the autoinhibition of the neck coil region (Huo et al., 
2012). Also, CC2 can fold back to interact with the FHA domain, which disrupts 
the motor activity (Hammond et al., 2009). Disruption of the CC1-FHA dimer 
severely impairs synaptic vesicle transport and locomotion in C. elegans 
worms, suggesting that robust dimerisation is crucially important for KIF1A 
function in vivo (Yue et al., 2013). 
Evidence for a tail block mechanism exists for KIF13B and KIF16B. In KIF16B, 
microtubule binding is inhibited by the interaction of the second and third 
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coiled-coil with the motor domain in an ATP dependent manner. This tail-
mediated inhibition is important for the correct localisation of early endosomes 
to somatodendritic regions in neurons and the recycling of AMPA and NGF 
receptors (Farkhondeh et al., 2015). An interaction of a tail domain with the 
motor domain also contributes to the autoinhibition of KIF13B (Yamada et al., 
2007, Yoshimura et al., 2010). Upon phosphorylation of KIF13B close to its C-
terminus by Par1b/MARK2 (microtubule affinity-regulating kinase), 14-3-3b 
binds and promotes the intramolecular interaction of KIF13B motor and tail 
domains. This in turn negatively regulates KIF13B microtubule binding, 
resulting in the dispersal of the motor in the cytoplasm and a reduction in cell 
protrusion and axon formation (Yoshimura et al., 2010). Also, KIF1C, which is 
known to exist as a stable dimer, interacts with 14-3-3 proteins in a 
phosphorylation-dependent manner (Dorner et al., 1999). However, whether 
this mediates an auto inhibitory tail – motor interaction similarly to KIF13B 
remains to be elucidated. 
Taken together, these data suggest specific autoinhibition mechanisms for 
each kinesin-3 family member. These might require different interaction 
partners to achieve release from autoinhibition and activate the motors for 
transport of specific cargoes. 
 
1.3.3.b. Activation by cargo interaction 
Many kinesins are activated upon cargo binding. Full-length KIF13B, 
also known as guanylate kinase-associated kinesin (GAKIN) exists in an 
autoinhibited state in solution. It is activated by the direct binding of its cargo 
human discs large (hDlg) tumour suppressor (Yamada et al., 2007). In contrast 
to KIF1A, full-length KIF13B is active in a gliding assay. This could be because 
the binding of the C-terminus to the glass surface might mimic the cargo-
bound state, thus relieving autoinhibition (Yamada et al., 2007). In contrast, 
KIF16B is a monomer in the cytoplasm and dimerises at the cargo surface. 
The localised dimerisation of KIF16B on early endosomes has been directly 
observed using Förster resonance energy transfer (FRET) in live cells 
(Soppina et al., 2014). Thus, these examples support the idea that due to the 
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diverse cargo binding tail, the different kinesin-3 family members use diverse 
means of autoinhibition and cargo-dependent release of inhibition, involving 
changes in the dimerisation status for some members and competitive binding 
of a peptide region that weakly interacts with the motor domain for others. The 
mechanisms of cargo-mediated activation thus require to be elucidated for 
each family member. 
While some motors bind their cargo directly, often cargo adapter proteins 
mediate both the motor activation and cargo recruitment. For C. elegans 
kinesin-3 motor UNC-104, a number of adapter proteins are known that are 
involved in cargo loading; a bimolecular fluorescence complementation assay 
(BiFC) was employed to show that binding of different adapters UNC-16 
(JIP3), DNC-1 (DCTN-1/Glued) and SYD-2 (Liprin-a) to UNC-104 results in 
translocation to different sub-cellular compartments in neuronal cells. This 
suggests that adaptor proteins are able to recruit the motor to their cargo and 
steer their transport (Wagner et al., 2009, Hsu et al., 2011). Further, binding 
of LIN-2 (CASK) and SYD-2 was shown to positively regulate the UNC-104 
motor by increasing its velocity and binding of LIN-2 also increased run 
lengths. The cargo transport of synaptobrevin-1 (SNB-1) was markedly 
reduced in the neurons of LIN-2 knockout worms implying that LIN-2 is an 
activator of UNC-104 motor (Wu et al., 2016). In Ustilago maydis, the cargo 
adapter Hook protein (Hok1) mediates the recruitment of Kin3 and dynein to 
early endosomes and regulates bi-directional motility. Hok1 releases Kin3 and 
this allows for dynein to bind and drive the subsequent change in directionality 
(Bielska et al., 2014). Similar to Kin3, KIF1C binds to another dynein adapter 
protein, Bicaudal-D-related protein 1 (BICDR-1) (Schlager et al., 2010). 
BICDR-1 also binds Rab6A vesicles, thus linking both motors to secretory 
vesicles and controlling the bi-directional vesicle transport in developing 
neurons (Schlager et al., 2010). Centaurin a1 (CENTA1) acts as a cargo 
adapter for KIF13B and recruits the motor to PtdIns(3,4)P2 / PtdIns(3,4,5)P3-
containing vesicles (Horiguchi et al., 2006, Tong et al., 2010). CENTA1 
contains two PH domains that bind the head groups of phosphoinositides, and 
PH1 also directly binds the FHA domain of KIF13B in a phosphorylation-
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independent manner (Tong et al., 2010). As KIF13B FHA simultaneously 
interacts with the ArfGAP domain of a second CENTA1 molecule, CENTA1-
KIF13B form a heterotetrameric transport complex for PtdIns(3,4,5)P3-rich 
vesicles (Horiguchi et al., 2006, Tong et al., 2010). 
 
1.3.3.c Regulation by Rab GTPases 
The members of the Rab family of GTPases are known to control the 
localization of vesicles/organelles in a nucleotide-dependent manner. Rab 
proteins act at all stages including vesicle formation, motility and tethering of 
vesicles to the designated compartment (Hutagalung and Novick, 2011). Rab 
GTPases exist in either GTP or GDP bound states, and are activated by GEFs 
(GTP/GDP exchange factors) and switched off by GAPs (GTPase activating 
factors) (Novick and Zerial, 1997). Once activated, the Rab proteins bind to 
vesicles that are translocated to the destination compartment, where they dock 
and fuse. The Rab proteins are then recycled back via a cytosolic intermediate 
(Zerial and McBride, 2001). 
KIF1A and KIF1Bβ both transport Rab3-coated vesicles in the axon. Rab3 is 
a synaptic vesicle protein that controls the exocytosis of synaptic vesicles 
(Fischer von Mollard et al., 1991, Stettler et al., 1994, Schluter et al., 2004). It 
has been found that DENN/MADD (Differentially expressed in normal and 
neoplastic cells/MAP kinase activating death domain), a GEF for Rab3, binds 
to Rab3 and the tail domain of KIF1A and KIF1Bβ and is thought to mediate 
the transport to the axon terminal while maintaining Rab3 in the GTP-bound 
form (Niwa et al., 2008).  
Rab6 binds to KIF1C at two sites, to the motor domain and near the C-
terminus. Rab6 binding to the motor domain disrupts the motor’s ability to bind 
microtubules (Lee et al., 2015), while the binding to the C-terminus might 
activate cargo loading and relief from autoinhibition. Secretory Rab6-vesicles 
are transported bi-directionally and it is thought that the dual ability of Rab6 to 
activate and inhibit KIF1C might regulate the directional switch. KIF1C also 
transports Rab11-positive vesicles for the recycling of integrins (Theisen et al., 
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2012). Whether Rab11 is directly involved in controlling the activity of KIF1C 
is as yet unclear.  
KIF13A binds to the active GTP-bound recycling endosomes associated with 
Rab11 and controls endosomal sorting and recycling of endosomal cargo 
(Delevoye et al., 2014). KIF16B transports Rab5-positive early endosomes 
and Rab14-positive vesicles in non-neuronal cells (Hoepfner et al., 2005, 
Ueno et al., 2011). To which extent these Rabs affect kinesin remains to be 
understood. 
 
1.3.3.d. Specificity for a subset of microtubule tracks 
The microtubule tracks on which kinesin motors walk are not uniform. 
Depending on the cell type or its differentiation status, cells express different 
tubulin isoforms, accumulate microtubules with different posttranslational 
modifications (PTMs) and also express different microtubule-associated 
proteins (MAPs) that decorate the microtubules. Kinesins are known to be 
sensitive to both changes to tubulin and MAP composition. 
Tubulin undergoes a diverse range of chemical modifications known as 
posttranslational modifications subsequent to polymerization into 
microtubules. These modifications mainly occur on the C-terminal tails of both 
alpha- and beta-tubulin and include the removal of terminal amino acids, such 
as detyrosination, and the addition of polyglutamate and polyglycine side 
chains (Hallak et al., 1977, Edde et al., 1990, Redeker et al., 1994). 
Considering that the kinesin-3-specific K-loop is thought to interact with the C-
terminal tail of b-tubulin, it is expected that changes in this region would impact 
kinesin-3 binding. Further modification at other sites of tubulin have been 
described such as the acetylation of K40 in a-tubulin and phosphorylation of 
tubulin at various sites (L'Hernault and Rosenbaum, 1985). These 
modifications may change the stability of microtubules and act as signposts 
for motor transport by selectively increasing or decreasing the affinity of certain 
motors to the microtubule (Janke, 2014). In line with this idea, knockdown of 
polyglutamylase PGs1 in ROSA22 mice decreases the localisation of KIF1A 
to neurites (Ikegami et al., 2007). However, in COS cells, the truncated, 
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constitutively active KIF1A (1-393) was a non-selective motor (Cai et al., 
2009). Similar to the finding in COS cells, the negative result could be due to 
the lack of modified microtubules in these cells rather than a different property 
of the motor and would require further investigation to elucidate.  
The subcellular localisation of KIF1C is regulated by acetylation in primary 
human macrophages in a way that suggests that tubulin acetylation is a 
negative signal for KIF1C transport (Bhuwania et al., 2014). Likewise, KIF1Bb 
and KIF1A have been reported to drive lysosomal transport preferentially 
along tyrosinated (i.e. non-modified) microtubules (Guardia et al., 2016). 
These data suggest that most kinesin-3 motors are sensitive to tubulin PTMs, 
but with different preferences. 
MAPs regulate the assembly and disassembly kinetics of microtubules as well 
as the interactions of motors with microtubules (van der Vaart et al., 2009, 
Atherton et al., 2013). Lattice-decorating MAPs such as the neuronal protein 
tau regulate the attachment rate and can act as roadblocks that affect motors 
differently, depending on their ability to take side or backwards steps to 
circumvent the roadblock (Schneider et al., 2015, Dixit et al., 2008, Seitz et 
al., 2002). 
For kinesin-3, MAPs known to regulate the motor include doublecortin like 
kinase-1 (DCLK-1), which regulates KIF1 transport of dense core vesicles 
(DCVs) along dendrites in neurons. DCLK-1 specifically binds to microtubules 
in dendrites, which acts as a positive signal to promote dendritic transport of 
KIF1 cargoes. In the absence of DCLK-1, KIF1 motors predominantly transport 
DCVs into the axon (Lipka et al., 2016). The microtubule plus end tracking 
protein CLASP is required to stimulate the trafficking of KIF1C (Efimova et al., 
2014). KIF1C has also been described to move with growing microtubule plus 
ends in cells (Kopp et al., 2006). This could be either due to the preference for 
unmodified (i.e. freshly assembled) microtubules (Bhuwania et al., 2014), or 
due to its fast transport speed and thus ability to catch up with the growing 
microtubule end (Rogers et al., 2001) or due to its interaction with CLASP 
(Efimova et al., 2014). 
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1.3.3.e. Cooperation of motors 
Kinesin-3s have been implicated in the bi-directional transport of cargo. 
This means that when a specific kinesin-3 is inhibited or depleted, the 
transport of its cargo both towards the plus and the minus end of the 
microtubule is impaired (Theisen et al., 2012, Ally et al., 2009, Tien et al., 
2011). It has been suggested that kinesin-3 cooperates with dynein in the bi-
directional transport of cargoes, but the mechanism underlying the mutual 
activation of these opposite-polarity motors remains to be elucidated 
(Hancock, 2014). It has been suggested that cooperation depends on the 
opposing force generated, resulting in a mechanical activation wherein any 
two opposite polarity motors that move along microtubules were able to 
activate their counterpart and drive bi-directional transport (Ally et al., 2009). 
Other proposed models include a steric inhibition mechanism whereby the 
direct interaction of the opposing motor or accessory protein relieves 
autoinhibition, and a microtubule tethering mechanism whereby the opposing 
motor is in a weakly bound state and acts as a processivity factor (Hancock, 
2014). This is different to the idea of tug-of-war that has been proposed and 
reconstituted for kinesin-1 and dynein-mediated transport, where the motors 
pull against each other and the strongest team wins, i.e. the number of motors 
of each type loaded to a cargo molecule and the force that each motor can 
produce determine the net movement of the cargo (Amrute-Nayak and 
Bullock, 2012, Derr et al., 2012). Potential linkers to facilitate cooperation of 
dynein and kinesin-3 include Hook and Bicaudal, cargo adaptor proteins that 
have been identified to interact with both dynein and kinesin-3 tail domains 
(Bielska et al., 2014, Schlager et al., 2010, Splinter et al., 2010, Fu and 
Holzbaur, 2014). Interestingly, the presence of BICD2 increases the force 
generation and processivity of dynein/dynactin (Belyy et al., 2016, Schlager et 
al., 2014), demonstrating that these cargo adaptor proteins regulate motor 
activity and could act as switches to control transport directionality within a 
complex containing two opposing motors. Other control mechanisms could 
come from accessory proteins such as kinesin binding protein (KBP), which 
has been shown to bind KIF1C, stimulate KIF1B, but inhibit KIF1A-mediated 
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bi-directional transport (Kevenaar et al., 2016, Drerup et al., 2016). If the 
activity of such regulatory proteins was spatially controlled, this would enable 
directional switching of transport complexes in the presence of opposing 
motors. 
 
1.4. KIF1C 
Figure 1.6: Primary Structure of KIF1C 
Schematic representation of the primary structure of KIF1C depicting different 
structural domains. The different proteins that are known to interact with KIF1C are 
depicted. Rab6A binds at the N and C-terminus (Lee et al., 2015), PTPD1 and Myosin 
IIA binds between the third and fourth coiled coil domain (Dorner et al., 1998) (Kopp 
et al., 2006), BICDR-1 and 14-3-3 proteins bind at the C-terminus (Schlager et al., 
2010) (Dorner et al., 1999). 
 
In a yeast two-hybrid screen using the FERM domain of a protein 
tyrosine phosphatase (PTPN21) as bait, KIF1C was identified as an interacting 
partner for the FERM domain (Dorner et al., 1998). KIF1C is a 1103 amino 
acid long N-kinesin, comprising of an N-terminal motor domain, a central FHA 
domain with coiled coil domains at either side and a proline rich domain 
towards the carboxy terminal of the protein (Fig 1.6). Among the various 
kinesin-3 family members, KIF1C is most similar to KIF1A and KIF1B in its 
sequence homology (Dorner et al., 1998). Kinesin-3 family members are 
implicated in long-distance cargo transport (Lipka et al., 2016, Theisen et al., 
2012) and consistent with this function, mutations in KIF1C have been 
reported to cause hereditary spastic paraplegia (HSP) and cerebral 
dysfunction in humans (Dor et al., 2013). Functional characterisation for these 
mutations are lacking. 
Cell lysate treatment with cross-linking agents detected endogenous KIF1C 
dimers, suggesting that KIF1C may be a dimeric motor protein (Dorner et al, 
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1999). KIF1C localizes to the Golgi apparatus and has been shown to be 
involved in the cargo transport from Golgi to endoplasmic reticulum (ER) 
(Dorner et al., 1998). However, knockout experiments in mice did not reveal 
any deleterious effects and fibroblasts from these mice had a functional Golgi 
to ER transport (Nakajima et al., 2002). This suggests that KIF1C is not the 
only motor involved in Golgi to ER transport and the pathway can be rescued 
by other motor proteins. More recently, KIF1C has been reported to be a key 
player in maintaining the Golgi structure along with Rab6, a direct KIF1C 
interacting partner (Lee et al., 2015). Depletion of either Rab6 or KIF1C 
resulted in Golgi fragmentation suggesting a co-operation between these two 
proteins. KIF1C has also been implicated in neuronal transport as an unbiased 
and fast neuronal cargo transporter as it can walk along axons and dendrites 
(Lipka et al., 2016). 
KIF1C also regulates podosome dynamics in macrophages and vascular 
smooth muscle cells (Kopp et al., 2006; Efimova et al., 2014; Bhuwania et al., 
2014) and tubulin acetylation has been shown to influence the subcellular 
localisation of KIF1C positive vesicles in primary macrophages (Bhuwania et 
al., 2014). KIF1C has also been shown to interact with Myosin IIA (Kopp et al., 
2006) which also localizes to podosomes (Kopp et al., 2006). Myosin IIA 
generates contractile forces involved in rear retraction (Vicente-Manzanares 
et al., 2009. It has been reported that in vascular smooth muscle cells 
(VSMCs) KIF1C fails to accumulate at the cell cortex in CLASP-depleted cells 
(Efimova et al.,2014) and recent reports from our lab show that KIF1C and 
PTPN21, a scaffolding phosphatase co-operate to mediate podosome 
formation in VSMCs (Bachmann et al, unpublished). 
KIF1C associates with different regulatory proteins, but the functional 
significance of these interactions is not very well understood. KIF1C and 
BICDR-1 (Bicaudal-D-related protein 1) are known to interact and to play a 
role in the bi-directional transport of secretory vesicles in young neurons 
(Schlager et al., 2010). BICDR-1 is a dynein cargo adapter and has been 
recently shown to recruit two dynein molecules by cryo electron microscopy 
(Grotjahn et al., 2017, Urnavicius et al., 2017). BICDR-1 also binds Rab6A 
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vesicles, which act as an intermediary protein that links the motor to the cargo 
(Schlager et al., 2010) and recently it was reported that KIF1C also binds Rab6 
at the motor domain and cargo-binding domain (Lee et al., 2015). Another 
binding partner for KIF1C that was identified recently was Hook3 which also 
binds dynein (Redwine et al., 2017). Whether Hook3 plays a similar role to 
that of BICDR-1 in bi-directional transport remains to be seen. 
KIF1C has been shown to bind to 14-3-3 scaffold family proteins via the 
phosphorylation carboxy-terminal serine 1092 (Dorner et al., 1999). 14-3-3 
proteins recognise and bind to phospho-serine and phospho-threonine 
proteins. They act as scaffolding proteins and mediate protein-protein 
interactions thereby regulating motor and cargo transport activity (Fu et al., 
2000, Tzivion and Avruch, 2002). 
KIF1C has also been implicated in regulating cellular adhesions in migrating 
cells. KIF1C transports α5β1- integrins into cellular protrusions and localizes 
to the tip of the tail in migrating cells (Theisen et al., 2012). The α5β1- integrin 
transport aids in maturation of trailing adhesions and maintenance of cell tails. 
Depletion of KIF1C in these cells hampers the tail stability and results in loss 
of directional persistence (Theisen et al., 2012). In addition to this, reports from 
our lab show that PTPN21 rescues KIF1C dependent α5 integrin transport in 
KIF1C depleted cells. PTPN21 emerges as an activator of KIF1C function in 
cells (Bachmann et al., unpublished). 
It is evident that KIF1C has a pivotal role to play in the regulation of cellular 
processes. Hence, it is important to elucidate the mechanism of kinesin 
activity, its interactions with other proteins to better understand intracellular 
cargo transport which is known to play a key role in the pathogenesis of 
neurological disorders and axonopathies. 
 
1.5. Outline of this work 
Previously it has been shown that (Bachmann et al, unpublished) 
PTPN21, a scaffolding phosphatase restores KIF1C mediated α5-integrin 
transport when overexpressed in KIF1C-depleted cells. Here, using 
hydrodynamic analysis the oligomeric status of KIF1C is elucidated. Next, 
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using purified proteins and single molecule motility assays the activation of 
KIF1C by PTPN21 is described. In cells, using structural domain analysis the 
region contributing to the tail localization of KIF1C is determined along with 
the negative regulation of KIF1C activity by 14-3-3 proteins. Finally, the 
mechanical properties of KIF1C and behaviour of HSP causing patient 
mutants are determined using the optical trapping system. 
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1. Cell Biology 
2.1.1. Mammalian cell maintenance  
The hTERT RPE-1 cells (Clonetech) were cultured in (DMEM/Nutrient 
F-12 Ham (Sigma) supplemented with 10 % FBS (Sigma), 2 mM L-Glutamine 
(Sigma), 2.3 g/l Sodium Bicarbonate (Sigma), 100 U/ml Penicillin (Sigma), 100 
μg/ml Streptomycin (Sigma) with 5 % CO2 in a humidified incubator. For cell 
maintenance, the RPE-1 cells were grown to 70 % confluency, washed with 
PBS and incubated with 0.05 % Trypsin and 0.02 % EDTA (w/v) solution 
(Sigma). Using an inverted microscope cell detachment was assessed and 
reseeded 1 in 10 in fresh pre-warmed RPE-1 growth medium. 
 
2.1.2. DNA transfection 
Cells were seeded onto flourodishes coated with 10 µg/ml fibronectin 
(Sigma) 24 hours before DNA transfection and the medium was replaced with 
fresh pre-warmed growth medium prior to DNA transfection. Fugene6 
(Promega) was used for plasmid transfection as described in Table 2. DNA 
was resuspended in Opti-MEM (Gibco) before Fugene6 addition. The 
transfection reaction was mixed well by pipetting and incubated for 30 minutes 
at room temperature before addition to cells. 
 35 mm quadrant fluorodish – per well 
Opti-MEM 37.5 µl 
Fugene6 1.125 µl 
DNA 0.375 µg 
Table 2 : Mammalian cell transfection 
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2.1.3. Insect cell maintenance 
SF9 cells (Invitrogen) were cultured in SF900 serum free medium 
(Gibco) supplemented with 100 U/ml Penicillin (Sigma), 100 μg/ml 
Streptomycin (Sigma) in a shaking incubator at 28ºC and 105 rpm. Cells were 
grown up to a density of 1.5×106 cells/ml and split 1 in 3 in fresh SF900 serum 
free medium. 
 
2.1.4. Insect cell transfection and generation of virus stocks 
The bacmid DNA and Escort IV (Sigma) were mixed well and added to 
cells resuspended at a density of 1×106 cells per well in a 24- deep well plate 
as described in Table 3. The transfection reaction was mixed well by pipetting 
and incubated for 30 minutes at room temperature before addition to cells. 
 24- deep well plate, per well 
Escort IV 12 µl 
SF900 media 1.125 µl 
DNA 7 µl 
Table 3 : Insect cell transfection 
 
After 5 to 7 days, the cells are spun down and the supernatant harbouring the 
virus is passed through a 0.45 µm filter and P1 (passage 1) virus stocks are 
collected. SF9 cells are then infected with 50 µl of P1 virus at a density of 
0.5×106 cells/ml. Post 36hrs the cells are harvested, resuspended in 70% 
SF900 SFM, 20% FBS and 10% DMSO, aliquoted as 500 µl and frozen in a 
cooling pot (Nalgene) and stored in -80ºC. These stocks are referred to as 
BIICs (Baculovirus Infected Insect Cells). 
 
2.2. Molecular Biology 
2.2.1. PCR 
PCR amplification was carried out using High-fidelity Phusion DNA 
polymerase (NEB) for cloning and Taq DNA polymerase (Fermentas) for gene 
expression analysis. The PCR mix was prepared in a total volume of 50 μl as 
in Table 4 and the cycling conditions used are described in Table 4. PCR 
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product amplification was confirmed by visualising 5 μl of PCR reaction mixed 
with 1 μl 6X Orange G loading buffer on an agarose gel. The product size was 
compared to the GeneRuler 1 kb ladder (Fermentas). When needed, PCR 
products were purified using PureLink Quick Gel Extraction Kit and/or 
PureLink Quick PCR Purification Kit as per manufacturers’ guidelines 
(Invitrogen) and resuspended in 50μl ddH2O. Primers used for PCR are listed 
in Table 5. 
Table 4 : PCR cycling conditions 
Name Primer sequence Remark 
UT05 
KIF1C F 
CAACACGGAGTCCCAGATTG  
UT170 
KIF1C R 
ACTGACCTTCTCCGAGTCC 
 
 
AS83 
eGFP R 
GCCGTTTACGTCGCCGTC 
 
 
AS358 
KIF1C-1479 R 
GAAGggatCCACAGTTCCCCCATCCTC 
 
BamHI 
AS359 
KIF1C-1837 R 
GGGGatCCCCTCGTTCCCGTTCC 
 
BamHI 
AS370 
KIf1C-2033 F 
CGGGGtcGACTCTGACAAGCGCTCTTG 
 
SalI 
AS376 
KIF1C F 
CTGCGGGTCtGGGAGCACC 
 
R169W 
AS416 
PTPN21-296 F 
TTGGAGTGGTGTTTTATGTGC  
AS460 
KIF1C-811 R 
CTCCACCTCCCCCGCTGTCCGAGTCTGC 
 
 
AS495 
KIF1C-950 R 
TGCgGatCCTGCAGCCGTAGCTGCTC BamHI 
AS496 
KIF1C-1043 R 
GCAGgAtCCGCTCCCCGGGATCGG BamHI 
AS497 
KIF1C R 
GACGGCAGCGTgCTGCCCCTGACC S1092A 
AS498 
KIF1C R 
GACGGCAGCGTgagGCCCCTGACCTC S1092E 
PCR Mix Final Concentration Step Temperature Time 
DNA 300 pM Denaturation 98ºC 2 min 
Forward & Reverse 
primer 
0.2 µM Annealing 60ºC 30 s 
dNTP 0.2 mM Extension 72ºC 30 s/kb 
Buffer 1X Step 2 to 4 repeated 34 times 
Phusion polymerase 1U Final extension 72ºC 10 min 
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AS528 
KIF1C R 
CTGCACGTACaGGCCCAGGATG 
 
P176L 
AS529 
pFB MCS F 
GATTACGATATCCCAACGACC 
 
 
AS556 
HA-Ezrin 
GAAACCCATATGGGATACCCATACGATGTTCCA 
GATTACGCTGTGGTGCCGAAACCAATCAATGTC 
 
NdeI 
AS557 
Ezrin-FERM R 
CGGTTgcggccgcTTTCTTCTCTGTTTCCAGCTG 
 
NotI 
AS558 
HA-tag 
AAGCTTcatATGGGATACCCATACGATGTTC 
 
NdeI 
AS559 
PTPN21-FERM 
R 
GAAGAAGCggccGcTTCTGTATAATGTCCATTATAGTG NotI 
AS592 
PTPN21-381 R 
GAGGTCAgcggccGCTCTATCCAAGCTTGTCTG NotI 
AS627 
KIF1C R 
CAGGGCTTCTGTCTcGgcTAGCTTCTCCTC 
 
R463A 
K464E 
AS628 
KIF1C R 
GTGATGGGCgAGAACCACGTTTTC 
 
K591E 
AS629 
KIF1C R 
CATAAAGCTGGcAATGGcGgcGgcGCTGCAGGATC 
 
E642A 
E644A 
K645A 
Table 5 : List of primers used 
The table depicts list of primers used in this study. Lower case indicates restriction 
sites and mutations. F – forward primer, R – reverse primer. 
 
2.2.2. Mutagenesis PCR 
Mutagenesis PCR was used to generate pKan-CMV-KIF1CS1092AGFP, 
pKan-CMV-KIF1CS1092EGFP, pFastBac-M13-KIF1CR463AK464EGFP, pFastBac-
M13-KIF1CK591EGFP and pFastBac-M13-KIF1CE642AE644AK645AGFP plasmids 
as described in 2.2.3 using the High-fidelity Phusion Polymerase (NEB). The 
PCR was carried out as indicated in Table 6. PCR product amplification was 
confirmed loading on an agarose gel. 
 
Table 6 : Mutagenesis PCR Mix 
PCR Mix Final concentration 
DNA 300 pM 
Upstream primer 
Mutagenic primer 
0.2 µM 
0.2 µM 
dNTP 0.2 mM 
Buffer 1X 
Phusion polymerase 1U 
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 Table 7: Mutagenesis PCR conditions 
 
2.2.3. Cloning 
Briefly, PCR products were digested with restriction enzymes from NEB 
and used as per manufacturer’s instructions. The digested backbone plasmids 
and inserts were visualized on an agarose gel and extracted using PureLink 
Quick Gel Extraction Kit. The fragments were ligated for 1 hr at 22ºC using T4 
DNA ligase (Thermo Scientific) and transformed into chemically competent 
TOP10 cells (Invitrogen) by subjecting to heat shock treatment at 42ºC for 45 
Cycle Step Temperature Time 
Initial denaturation 98ºC 2min 
Denaturation 98ºC 10 s 
Annealing 60ºC 30 s 
Extension 72ºC 30 s/kb 
Step 2 to 4 repeated 9 times 
72ºC, pause - Addition of 1 µM downstream primer 
Denaturation 98ºC 10 s 
Annealing 60ºC 30 s 
Extension 72ºC 20 s 
Step 6 to 8 repeated 9 times 
72ºC, pause -  Addition of 1 µM upstream primer 
10 98ºC 10 s 
11 65ºC 30 s 
12 72ºC 20 s 
Step 10 to 12 repeated 9 times 
72ºC, 10 min 
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s. The transformed mix was allowed to propagate for 1hr at 37ºC before plating 
it on a LB agar plate with suitable antibiotic. Single colonies from the plate 
were then picked and the DNA was extracted by Plasmid DNA Miniprep kit 
(Bio Basic), followed by restriction digestion and sequencing to confirm 
positive clones. 
pKan-RIP-KIF1C1-950GFP was generated by using primers UT05 and 
AS495 on the template pKan-RIP-KIF1CGFP. The insert and vector were 
digested with SalI - BamHI and ligated. 
pKan-RIP-KIF1C1-1043GFP was generated by using primers UT05 and 
AS496 on the template pKan-RIP-KIF1CGFP. The insert and vector were 
digested with SalI - BamHI and ligated. 
pKan- RIP -KIF1CD623-D679GFP was generated by using primers AS370 
and AS83 on the template pKan-RIP-KIF1CGFP. The insert and vector were 
digested with SalI - BamHI and ligated. 
pKan- RIP -KIF1CS1092AGFP was generated by using primers UT05 and 
AS83 along with mutagenic primer AS497 on the template pKan-RIP-
KIF1CGFP. The insert and vector were digested with SalI - BamHI and ligated. 
pKan- RIP -KIF1CS1092EGFP was generated by using primers UT05 and 
AS83 along with mutagenic primer AS498 on the template pKan-RIP-
KIF1CGFP. The insert and vector were digested with SalI - BamHI and ligated. 
pFastBac-M13-KIF1CGFP-MBN was generated by digesting pKIF1C-
GFP with EcoRI - MfeI and replacing it in the backbone of pFastBac-M13. The 
positive clone was then subjected to mung bean nuclease at the EcoRI site to 
correct the frame shift in the ORF. The positive clones were transformed with 
DH10Bac (Invitrogen) competent cells and plated on LB supplemented with 
kanamycin (30 µg/ml), gentamycin (7 µg/ml), tetracycline (10 µg/ml), IPTG (40 
µg/ml), X-Gal (100 µg/ml) for blue-white screening. Positive bacmid 
transformants (white colonies) were screened by PCR using M13 forward and 
reverse primers and internal gene primers for the integration into the viral 
genome. 
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pFastBac-M13-KIF1CR463AK464EGFP was generated by using primers 
AS359 and pFB5’ along with mutagenic primer AS627 on the template 
pFastBac-M13-KIF1CGFP-MBN. The insert and vector were digested with 
BsiWI-NdeI and ligated. 
pKan-RIP-KIF1CR463AK464EGFP was generated by Daniel Roth by 
digesting pFastBac-M13-KIF1CR463AK464EGFP with BsiWI-BamHI and 
replacing it in pKan-RIP-KIF1CGFP. The insert and vector were ligated. 
pFastBac-M13-KIF1CK591EGFP was generated by using primers AS460 
and pFB5’ along with mutagenic primer AS628 on the template pFastBac-
M13-KIF1CGFP-MBN. The insert and vector were digested with BsiWI-SalI 
and ligated. 
pKan- RIP-KIF1CK591EGFP was generated by Daniel Roth by digesting 
pFastBac-M13-KIF1CK591EGFP with BsiWI-BamHI and replacing it in pKan-
RIP-KIF1CGFP. The insert and vector were ligated. 
pFastBac-M13-KIF1CE642AE644AK645AGFP generated by using primers 
UT05 and AS83 along with mutagenic primer AS629 on the template 
pFastBac-M13-KIF1CGFP-MBN. The insert and vector were digested with 
SalI-BamHI and ligated. 
pKan- RIP -KIF1CE642AE644AK645AGFP was generated by Daniel Roth by 
digesting pFastBac-M13-KIF1CE642AE644AK645AGFP with BsiWI-BamHI and 
replacing it in pKan-RIP-KIF1CGFP. The insert and vector were ligated. 
pFastBac-M13-KIF1CGFPP176L was generated by using primers AS358 
and pFB5’ along with mutagenic primer AS528 on the template pFastBac-
M13-KIF1CGFP-MBN. The insert and vector were digested with AscI-StuI and 
ligated. 
pFastBac-M13-KIF1CGFPR169W was generated by using primers 
UT170 and pFB5’ along with mutagenic primer AS376 on the template 
pFastBac-M13-KIF1CGFP-MBN. The insert and vector were digested with 
AscI-BsiWI and ligated. 
pET22b-HA-PTPN211-3786HIS was generated by using AS558 and 
AS559 on the template pHA-PTPN21-eGFP. The insert and vector were 
digested with NdeI - NotI followed by ligation, transformation and screening 
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for positive clones. The positive close was transformed with BL21 DE3 
competent cells for expression. 
pET22b-HA-PTPN211-3816HIS was generated by using AS416 and 
AS592 on the template pHA-PTPN21-eGFP. The insert and vector (pET22b-
HA-PTPN211-3786His) were digested with BsrGI - NotI followed by ligation, 
transformation and screening for positive clones. The positive clone was 
transformed with BL21 DE3 competent cells for expression. 
pET22b-HA-Ezrin1-3286HIS was generated by using AS556 and AS557 
on the template pRSETC_6HISEzrin. The insert and vector were digested with 
NdeI-NotI followed by ligation, transformation and screening for positive 
clones. The positive clone was transformed with BL21 DE3 competent cells 
for expression. 
 
2.2.4. Protein Expression  
SF9 cells were infected with BIIC stocks and protein expression was 
monitored for 120 hr by taking a sample out every 24hr followed by SDS-
PAGE and immunoblotting to determine the peak of protein expression. For 
large-scale expression, 500ml of SF9 cells at a density of 1-1.5×106 cells/ml 
were infected with one vial of BIIC as described in (Wasilko et al., 2009). Post 
72hrs, cells were harvested by spinning at 252 × g for 20 min. The weight of 
the cell pellet was noted. The pellet was resuspended in 4 ml of SF9 lysis 
buffer (Table 7) per gram of the cell pellet, supplemented with 0.1 mM ATP 
and protease inhibitor cocktail (Roche) to prevent proteolytic degradation and 
snap frozen in liquid nitrogen until further use. 
Bacterial expression plasmids transformed with BL21 DE3 and were 
grown overnight as 3ml starter cultures. The starter cultures were diluted 1:100 
and grown in 200 ml of 2×YT (yeast extract, tryptone) at 37ºC, 180 rpm until 
they reached an optical density (OD600) of 0.5. The cultures were then induced 
with IPTG (Isopropyl β-D-1-thiogalactopyranoside; Melford) at a final 
concentration of 500 µM and the temperature was reduced to 16ºC for 
overnight expression. Next morning the cells we harvested at 1500 × g and 
resuspended in bacterial lysis buffer (Table 7) supplemented with 200 mM 
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phenylmethanesulfonyl fluoride (PMSF; Melford) at a dilution of 1:200 to inhibit 
proteolytic degradation and snap frozen in liquid nitrogen until further use. 
 
2.2.5. Protein Purification 
Protein purification was carried out in a two-step process. Harvested 
cell pellets were resuspended in SP lysis buffers according to the requirement. 
The cells were lysed using a douncer (Wheaton) with 20 strokes. Bacterial cell 
pellets were sonicated at 4ºC. Lysates were then cleared by spinning at 38000 
× g for 30min at 4ºC. SP Sepharose beads (GE Healthcare) were equilibrated 
with the lysis buffer and the cleared lysate obtained after the spin is mixed with 
the beads and batch bound for 1hr at 4ºC. Next, the beads were loaded onto 
a 5ml disposable polypropylene gravity column (Thermo Scientific) and 
washed with 10 - CV (column volume) until the OD280 is below 0.05. The 
protein was then eluted from the beads by the addition of SP elution buffer 
(Table 9, 11). The peak fractions obtained were pooled and diluted to the Ni-
NTA lysis buffer and batch bound with the Ni-NTA beads (Qiagen) for 1hr at 
4ºC. Next, the beads were loaded onto a gravity column and washed with 
10CV until the OD280 is below 0.05. The protein was then eluted from the beads 
with the Ni-NTA elution buffer (Table 10, 12). The peak fractions were run on 
a SDS-PAGE gel for visualisation and protein was aliquoted and flash frozen. 
SF9 lysis buffer Bacterial lysis buffer 
50 mM Sodium phosphate pH 7.5 
150 mM Sodium Chloride 
20 mM Imidazole 
0.1% Tween 20,1.5 mM MgCl2 
50 mM Sodium phosphate pH 7.5 
50 mM Sodium Chloride 
20 mM Imidazole 
1.5 mM MgCl2 
Table 8: Lysis Buffers used 
 
SF9 SP wash buffer SF9 SP elution buffer 
50 mM Sodium phosphate pH 7.5 
150 mM Sodium Chloride 
50 mM Sodium phosphate pH 7.5 
300 mM Sodium Chloride 
Table 9: SF9 SP buffers 
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SF9 Ni-NTA wash buffer SF9 Ni-NTA elution buffer 
50 mM Sodium phosphate pH 7.5 
150 mM Sodium Chloride 
50 mM Imidazole 
10% glycerol 
50 mM Sodium phosphate pH 7.5 
150 mM Sodium Chloride 
150 mM Imidazole 
0.1 mM ATP, 10% glycerol 
Table 10: SF9 Ni-NTA buffers 
 
Bacterial SP wash buffer Bacterial SP elution buffer 
50 mM Sodium phosphate pH 7.5 
50 mM Sodium Chloride 
50 mM Sodium phosphate pH 7.5 
200 mM Sodium Chloride 
Table 11: Bacterial SP buffers 
 
Bacterial Ni-NTA wash buffer Bacterial Ni-NTA elution buffer 
50 mM Sodium phosphate pH 7.5 
50 mM Sodium Chloride  
20 mM Imidazole 
10% glycerol 
50 mM Sodium phosphate pH 7.5 
50 mM Sodium Chloride 
150 mM Imidazole 
10% glycerol 
Table 12: Bacterial Ni-NTA buffers 
 
2.3. Biochemistry 
2.3.1. Size exclusion chromatography (SEC) 
 To determine the stokes radius, SEC was carried out using Superdex 
200 (GE Healthcare) column on the AKTApurifier10 FPLC with a UNICORN 
control system (GE Healthcare). The column was equilibrated with the SEC 
Buffer (Table 13). Protein was injected into the column and the fractions were 
collected using the fraction collector. 100 µl of 5 mg/ml standard proteins were 
injected individually. The Stokes radius for the standard proteins used were as 
follows thyroglobulin-8.5 nm, apoferritin-6.1 nm, glucose oxidase-4.3 nm, 
bovine serum albumin-3.48 nm. The fractions were run on a SDS-PAGE gel 
for visualisation, where necessary immunoblotting was carried out. Stokes 
radius Rs was determined according to (Erickson, 2009). 
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SEC Buffer 
35 mM Sodium phosphate pH 7.5 
150/500 mM Sodium Chloride 
1.5 mM MgCl2 
Table 13: SEC buffer 
2.3.2. Analytical ultracentrifugation/ Glycerol gradients 
 10 - 40% vol/vol glycerol gradients were made using the Gradient 
master (Biocomp) with the buffer listed in Table 13. The 5 ml polyallomer tubes 
(Beckman) were marked using the metal marker in the middle at 2.5 ml. Next, 
2.5 ml of 10% glycerol buffer was added into the tube using a syringe. Next, 
2.5 ml of 40% glycerol buffer was added to the bottom of the tube containing 
the 10% glycerol buffer until the 2.5 ml mark. Where necessary the salt 
concentration was adjusted. The protein sample was loaded on top of the 
gradient and the samples were spun at 364496 × g for 16 hrs at 4ºC. 100 µl 
of 5mg/ml standard proteins were loaded individually on separate gradients. 
The sedimentation co-efficient of standard proteins were as follows – 
apoferritin- 16.6 S, catalase-11.3 S, glucose oxidase-8 S, bovine serum 
albumin-4.6 S. The next day, 250 µl aliquots were carefully taken out from the 
top of the gradient tubes and the A280 was measured to determine the peak in 
the gradient. The samples were processed for SDS-PAGE and 
immunoblotting where necessary. The frictional ratio was 
determined ƒ/ƒmin = Smax/S with Smax = 0.00361·M2/3 in Svedberg for a protein 
of mass M in Daltons (Erickson, 2009). 
Analytical Ultracentrifugation buffer 
35 mM Sodium phosphate pH 7.5 
1.5 mM MgCl2 
50 mM Sodium Chloride 
0.1 mM ATP 
1 mM EGTA 
40% glycerol 
35 mM Sodium phosphate pH 7.5 
1.5 mM MgCl2 
50 mM Sodium Chloride 
0.1 mM ATP 
1 mM EGTA 
10% glycerol 
Table 14: Analytical Ultracentrifugation buffer 
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2.3.3. Crosslinking mass-spectrometry 
The two cross-linkers that were used were BS3 (bis (sulpho- 
succinimidyl) suberate) and EDC (1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide). BS3 has a spacer arm of 11 Å and reacts with primary amines 
in lysine side chains. EDC cross-links with amines (lysine, protein N-terminus) 
and directly cross-links atoms of the protein with each other in a 3 Å cross-
link. Freshly prepared cross-linker (5 mM) was mixed by pipetting with the 
protein of interest (500 nM) in solution. For EDC cross-linking, N-
hydroxysulfosuccinnimide (3 mM) was added to improve efficiency of the 
cross-linking. The reaction was incubated at room temperature for an hour 
shaking at 400 rpm and quenched with Tris buffer pH 7.5 to a final 
concentration of 50 mM. Next, the protein was diluted in 50 mM Ammonium 
bicarbonate and reduced using 1 mM DTT for 60 min at room temperature. 
The sample was then alkylated with 5.5 mM iodoacetamide for 20 min in the 
dark at room temperature and digested using (1 µg per 100 µg of protein) 
trypsin (sequencing grade; Promega) overnight at 37°C. The Cross-linked 
peptides were de-salted using C18 stage tips (Rappsilber et al., 2007). The 
samples were then analysed in the Proteomics facility (WPH RTP), University 
of Warwick. Briefly, an aliquot containing 20 µl of extracted peptides (total 
sample volume 50 µl) from each sample was analysed by nano LC-ESI-
MS/MS using the Ultimate 3000/Orbitrap Fusion instrumentation (Thermo 
Scientific) using a 60 minute LC separation on a 50cm column. The resulting 
sequences are visualized using Scaffold (Proteome software) for percentage 
coverage and purity followed by analysis using StavroX (Gotze et al., 2015). 
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2.3.5. In-vitro Tubulin polymerisation 
 Tubulin was prepared from porcine brains according to protocols 
published (Gell et al., 2011). Microtubules were polymerised in MRB80 buffer 
(Table 14) in a two-step reaction to generate long microtubules. First 16 µM 
pig-brain tubulin was polymerised with 1 mM GTP (Jena Biosciences) at 37°C 
for 30 minutes, stabilized by addition of 100 μM Paclitaxel (Sigma) to generate 
seeds. These unlabelled polymerised microtubule seeds (0.16 µM) were 
mixed with pig-brain tubulin, biotin-tubulin (Cytoskeleton Inc.), Hilyte647-
labelled tubulin (Cytoskeleton Inc.), in the molar ratio of 25:1:2 in the presence 
of 1 mM GTP (Jena Biosciences) and incubated at 37°C for 30 minutes. 
Microtubules were stabilized by addition of 100 μM Paclitaxel (Sigma). To 
remove free tubulin, microtubules were pelleted at 100,000 × g for 10 min at 
room temperature in an airfuge (Beckmann Coulter), washed with and 
resuspended in MRB80 and 100 μM Taxol. 
MRB80 Buffer 
80 mM K-Pipes pH 6.8 
4 mM MgCl2 
1 mM EGTA 
Table 15: MRB80 Buffer 
 
2.3.6. Single molecule motility assay 
 Flow chambers were made using clean glass slides and double sided 
sticky tape (Scotch 3M) as shown in Figure 2.1. Coverslips (22×22) were 
cleaned by incubating in 2.3 M hydrochloric acid overnight at 60ºC. The next 
day, coverslips were washed with Millipore water and sonicated at 60ºC for 5 
min. The wash cycle was repeated 5 times. The coverslips were dried using a 
Spin Clean (Technical video) and plasma cleaned using Henniker plasma 
clean (HPT-200) for 3 min and placed on top of the glass slide making a 100 
µm deep flow chamber. The surface was coated with (0.2 mg/ml) PLL(20)-
g[3.5]-PEG(2)/PEG(3.4)-Biotin (50%) (Susos AG). Biotin-647-microtubules 
were attached to this surface with streptavidin (5mg/ml) and the surface was 
blocked with κ-casein (1 mg/ml) (Sigma). KIF1C, PTPN21 and Ezrin-FERM 
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were pre-spun. KIF1C was incubated with either buffer or PTPN21 or Ezrin-
FERM for 15min at room temperature, following which the motility mix (Table 
16) was flown in and the chamber was sealed with candle wax. 
Figure 2.1: Motility flow chamber 
Schematic representation of a single molecule motility chamber. A clean glass slide 
was taped with double sided sticky tape was and a clean coverslip to make a flow 
chamber. 
Motility Mix 
3-10 nM Motor protein 
1 mM ATP 
5 mM Phosphocreatine 
7 U/ml Creatine phosphokinase 
0.2 mg/ml Catalase 
0.4 mg/ml Glucose oxidase 
4 mM DTT 
50 mM Glucose 
25 mM KCl 
100 µM Taxol 
 0.2 mg/ml κ-casein 
Table 16: Motility mix 
 
2.4. Microscopy and Data Analyses 
2.4.1. Live-cell Imaging 
 Live cells were imaged using a 60x oil NA 1.4 objective on an Olympus 
Deltavision microscope (Applied Precision, LLC). The microscope is equipped 
with eGFP, mCherry filter sets and a CoolSNAP HQ2 camera (Roper 
Scientific) under the control of SoftWorx (Applied Precision). The environment 
was tightly controlled at 37ºC and 5% CO2 using a stage-top incubator (Tokai 
Hit) and a weather station (Precision control). Images were acquired with 
500ms exposure every 2 s for 180 s. The fluorescent intensity was measured 
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at the tail and front of the cell and corrected for background in the GFP and 
mCherry channel using ImageJ software (Fig 2.2). To determine the ratio of 
accumulation at the tail or front, the mean intensities measured at the tail and 
the front in the GFP channel was divided to mean intensity measured at the 
tail and the front in the mCherry channel. 
Figure 2.2: Intensity measurements 
Schematic representation of the measurement of the ratio of mean intensity at the 
front or tail of a cell. A region of interest was drawn manually surrounding the 
accumulation observed and the mean intensity was measured at the tail, front, 
cytoplasm and background in both channels. Similarly, for cells that were more or 
less round (deletion constructs) the mean intensity was measured at the 
accumulation peaks. 
 
2.4.2. TIRF Microscopy and Image analysis 
  Single molecule motility assay was observed on an Olympus TIRF 
system using a 100x NA 1.49 objective, 1x additional magnification, 488 nm, 
and 640 nm laser lines, an ImageEM emCCD camera (Hamamatsu 
Photonics), an environmental chamber and a stage-top-incubator (Okolab, 
Ottaviano, Italy) under the control of xcellence software (Olympus). Images 
were acquired every 100 ms for 180 s at an exposure of 60 ms unless 
otherwise mentioned. The images were analysed by drawing kymographs on 
microtubules of line width 11, which covers and averages intensity over 11 
pixels using the Kymograph plugin (Seitz and Surrey, 2006). The runs were 
identified manually by scoring the kymographs for runs and static motors. The 
speed and run length was calculated from the length and slope of each run 
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using a macro written by Dr. Anne Straube. The runs with “stop & go” events 
were analysed as separate phases to distinguish between the two events. 
Blind analysis was also carried out independently for an unbiased scoring of 
the data sets. 
 
2.5. Optical Trapping  
 560 nm Polystyrene beads and motor protein were incubated together 
in the assay buffer containing 80 mM PIPES (Piperazine-1,4-bis (2-
ethanesulfonic acid)) pH 7, 2 mM MgSO4, 1 mM EGTA, 1 mM DTT, 3 mg/ml 
D-glucose, 0.2 mg/ml κ-casein and 1 µM ATP. The concentration of motor was 
decreased such that only 20-30% of the beads moved. Flow cells were 
constructed using plasma cleaned coverslips and Dow Corning High Vacuum 
Grease. Two lines of grease were applied to the base coverslip (22 x 50 mm) 
using a syringe, the top coverslip (22 x 22 mm) was placed, forming a flow cell 
of approximately 10 μl capacity. Glutaraldehyde (8%) was added to the 
chamber and incubated for 2 hr followed by washing the flow cell with 200 µl 
of Millipore water. The microtubules were diluted to the required concentration 
and were introduced to the flow cell and allowed to adsorb on to the surface 
coated with glutaraldehyde. The microtubules were incubated for an hour to 
allow for adsorption. Next, 0.2 µl of bead-motor protein solution was diluted in 
20 µl of assay buffer composed of BRB80, 1 mM ATP, 0.4 mg/ml κ-casein, 10 
µM taxol and 0.4 µl of the oxygen scavenger (1 mg/ml catalase, 5 mg/ml 
Glucose oxidase, 3 mg/ml D-glucose, 50% glycerol in the assay buffer). The 
beads were then introduced to the cell using capillary action to draw the 
solution through. The flow chamber was viewed immediately using the Optical 
Trap setup (Carter and Cross, 2005). The images were acquired at 20 kHz for 
180 s and the image analysis was carried out using code written in R by Dr. 
Algirdas Toleikis unless otherwise mentioned. Briefly, a moving window t-test 
algorithm (Carter and Cross, 2005) was used which identifies a step based on 
a t-test with the following parameters – t-test score threshold=30, minimum 
step size=5 nm, minimum force=1 pN, moving average, n=20. The size of the 
window and the threshold are varied to determine accurate steps. 
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2.6. Statistical Analysis and figure preparation 
 Statistical data analyses and graphs were generated using Origin Pro 
8.5 (OriginLab) unless otherwise mentioned. Box plots show quartiles, 10-90% 
data. All statistical significance analyses were carried out using two-sample t-
tests assuming equal variance unless otherwise mentioned. Figures were 
prepared using Adobe Illustrator. 
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CHAPTER 3 CONFIRMATION OF PTPN21 FERM DOMAIN AS 
AN ACTIVATOR OF KIF1C 
 
 The two well-known modes of kinesin motor activation are the tail-block 
model and the monomer to dimer switch model. In the tail-block model, the 
protein is a stable dimer and the tail interacts with the head to keep the motor 
in an autoinhibited state. Upon binding by an adapter protein or cargo the 
motor is activated (Yamada et al., 2007, Hammond et al., 2009, Farkhondeh 
et al., 2015, Yoshimura et al., 2010). In the monomer to dimer switch model, 
the intramolecular interactions between the neck and tail regions hold the 
kinesin motors in a monomeric, inactive state. Upon activation by cargo, these 
motors dimerize with their neck coil and tail regions (Soppina et al., 2014, 
Okada and Hirokawa, 1999, Tomishige et al., 2002). 
However, it remains to be elucidated what the mode of activation is for KIF1C. 
Previous reports from our lab show that KIF1C transports integrin vesicles 
(Theisen et al., 2012) and further to this, KIF1C depletion leads to a decrease 
in integrin vesicle motility as tested in two different cellular models. This 
phenotype could be rescued by expressing the FERM domain of a 
phosphatase – PTPN21, which compensates for KIF1C depletion. The 
addition of FERM domain of PTPN21 could either activate and mobilize the 
remaining KIF1C pool present in the cell or there is another motor that is being 
activated (unpublished data, Straube Lab). 
To test in-vitro whether PTPN21 FERM domain activates KIF1C directly and 
to determine the mechanism of activation, it was essential to purify full-length 
KIF1C and determine the hydrodynamic properties. 
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3.1. Purification of KIF1C 
 KIF1C was expressed in SF9 insect cells with an amino-terminal hexa-
histidine tag and a carboxy-terminal GFP tag. Purification was carried out in a 
two-step process by anion exchange chromatography using SP-Sepharose 
beads and affinity chromatography using Ni-NTA beads. 
In the first trial, affinity chromatography was performed to selectively bind 
KIF1C via the 6His tag. This was followed by anion exchange chromatography 
to remove the non-specific proteins contaminating the Ni-NTA purification. The 
resulting protein obtained still contained impurities and buffer exchange was 
required to bring the protein in a suitable buffer for subsequent experiments. 
Hence, in the second trial, anion chromatography was carried out first (Fig 3.1 
a) followed by affinity chromatography (Fig 3.1 b) to yield a clean protein at 
154kD as visualized by SDS-PAGE. To determine the purity of the sample, in-
solution mass spectrometry was carried out and KIF1C-GFP was confirmed 
to be the most abundant protein (Table 17). 
Figure 3.1: Purification of full-length KIF1C 
(a) Coomassie gel of 6His-KIF1C-GFP after anion exchange chromatography. The 
lysate was bound to SP-Sepharose beads and the column was washed with 150 mM 
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NaCl SF9 SP wash buffer and eluted with 300 mM NaCl. Elutions E3-E6 were pooled 
and bound to Ni-NTA beads for affinity chromatography. (b) Coomassie gel of 6His-
KIF1C-GFP after affinity chromatography. The elutions E3-E6 from SP were bound 
to Ni-NTA beads and washed with 50 mM Imidazole SP Ni-NTA Buffers and eluted 
with 150 mM Imidazole. Elutions E2 – E5 were stored for subsequent experiments. 
 
Name of protein identified Peptide count 
KIF1C 70 
Trypsin 3 
Fragile X mental retardation syndrome related protein 2 
Table 17: Mass-spec analysis of KIF1C-GFP for purity 
The protein was digested with trypsin and mass-spectrometry was carried out. The 
peptide count gives the total number of unique peptides identified by Scaffold 
software. KIF1C dominated the list of peptides that were identified. The other proteins 
that were identified were trypsin, which was used to digest KIF1C and a Fragile X 
mental retardation syndrome related protein. 
 
3.2. Hydrodynamic Analysis 
 The two modes of motor activation can be distinguished by determining 
if the motor is a monomer or a dimer. To do this, hydrodynamic analysis of 
KIF1C was carried out. Hydrodynamic analysis involves techniques such as 
size exclusion chromatography which determines the stokes radius and 
glycerol gradient centrifugation which gives the sedimentation co-efficient of 
the protein. From these parameters the size, shape and the conformation state 
of the motor protein can be estimated (Erickson, 2009). 
 
3.2.1. Determining Stokes Radius by Size exclusion chromatography 
Size exclusion chromatography separates proteins on the basis of the 
Stokes radius (RS) of the molecule (Fig 3.2). For a given protein of interest, 
this can be calculated relative to the Stokes radii of the standard proteins run 
independently on the size exclusion column. 
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Figure 3.2: Size exclusion chromatography 
Proteins are separated based on their shape and mass. Proteins with different shapes 
but similar molecular mass elute at different rates. 
 
To estimate the stokes radius for KIF1C-GFP, the protein was expressed from 
insect cells and subjected to a single step Ni-NTA purification process and the 
elution was run on the size exclusion column at two different salt 
concentrations. The elution fractions were measured in the NanoDrop 3300 
Fluorospectrometer (Thermo Scientific) to confirm the presence of KIF1C-
GFP (Fig 3.3). 
Figure 3.3: Determination of RS for KIF1C-GFP 
(a) KIF1C-GFP was injected into a size exclusion column at physiological and a high 
salt concentration of 150 mM NaCl and 500 mM NaCl respectively. The fractions 
containing KIF1C-GFP were measured in the NanoDrop 3300 Fluorospectrometer. 
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The elution volume at 150 mM NaCl for KIF1C-GFP was found to be 58.5 ml whereas 
with 500 mM NaCl it was 56 ml as indicated by grey and orange profile respectively. 
(b) Standard proteins were run on the size exclusion column independently to 
determine elution volume, which is plotted against known Stokes radii. (c) The Stokes 
radius for KIF1C-GFP was calculated from the formula derived from the standard 
curve to be 5.8 nm at 150 mM NaCl and 6.4 nm at 500 mM NaCl. 
 
The stokes radius for KIF1C-GFP was calculated by plotting elution 
volume versus known stokes radii of the standard proteins (Erickson, 2009). 
At physiological levels (150 mM NaCl) the stokes radius for KIF1C-GFP was 
found to be 5.8 nm and increasing the ionic strength to 500 mM NaCl resulted 
in a stokes radius of 6.4 nm (Fig 3.3). The experiment has been independently 
repeated twice and similar elution profiles were observed. The profile of 
KIF1C-GFP at 150 mM salt versus at 500 mM salt depicts a shift in the elution 
volume suggesting that KIF1C-GFP possibly changes conformation at a 
higher salt concentration. Increasing the ionic strength could either lead to the 
motor transitioning to a monomer or if the motor is compact, it could become 
elongated. But, in the former case, the monomer protein molecules would 
elute after the dimeric peak of KIF1C. Since, there was no detectable 
monomer peak of KIF1C observed, another possibility could be that the motor 
is in an equilibrium between two states which results in a peak (orange) that 
elutes just before the dimeric peak of KIF1C (grey). Next, to validate these 
results and to estimate the molecular mass, glycerol gradient centrifugation 
was carried out. 
 
3.2.2. Determining Sedimentation co-efficient by Glycerol gradient 
centrifugation 
Sedimentation co-efficient (S) as revealed by a glycerol gradient 
centrifugation determines how fast a protein moves through a gradient. (Fig 
3.4). Bulky and compact molecules travel farther down the gradient whereas 
lighter and linear molecules sediment slower. The sedimentation co-efficient 
for a target protein can be determined relative to the S values of the standard 
proteins of known sedimentation co-efficient that are run across independent 
gradients. 
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 Figure 3.4: Glycerol gradient sedimentation 
Proteins are separated based on their rate of sedimentation. Higher molecular mass 
proteins sediment faster than lower ones while linear molecules sediment slower than 
compact protein molecules. 
 
KIF1C-GFP was purified by a single step Ni-NTA column and the elutions were 
loaded onto a gradient of 10-40% glycerol at different salt concentrations. The 
standard proteins of known sedimentation co-efficients were run 
independently in separate gradients and the sedimentation co-efficient for 
KIF1C-GFP was calculated from the standard curve. There was a shift in the 
migration pattern that was observed with the increase in ionic strength (Fig 
3.5). At physiological conditions (0-150 mM NaCl), KIF1C-GFP was found to 
have a sedimentation co-efficient of 11 S and at higher ionic strength (500 
mM) the sedimentation co-efficient reduced to around 8 S (Fig 3.5b). A similar 
observation has been reported for kinesin-1 in which the motor protein 
transitions from 9 S to 6 S as the ionic strength increases (Hackney et al., 
1992). For kinesin-1, this results in a conformation change from a folded to an 
extended one. Our data suggests a similar effect could be occurring in case 
of KIF1C-GFP as well, where the motor is compact and transitions to an 
elongated state resulting in a lower sedimentation rate. 
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Figure 3.5: Behaviour of KIF1C at increasing concentration of NaCl 
(a) KIF1C-GFP was loaded onto a 10-40 % glycerol gradient at increasing salt 
concentrations in separate gradients. Fractions were collected from the top of the 
gradients and run on a SDS-PAGE followed by immunoblotting to determine the 
profile at different salt concentrations. The standards were run independently at 150 
mM salt concentration. GO – Glucose oxidase, BSA – Bovine serum albumin. The 
peak elution volumes at different salt concentrations are indicated by green arrow 
heads. (b) Standard proteins were run on a 10-40 % gradient independently to 
determine elution volume, which is plotted against known sedimentation co-efficient. 
(c) The sedimentation co-efficient for KIF1C-GFP was calculated from the formula 
derived from the standard curve to be 9.8 S at 150 mM NaCl and 8.1 S at 500 mM 
NaCl. The sedimentation co-efficient calculated at different salt concentrations is 
depicted in orange. 
 
3.2.3. Calculation of molecular mass  
 From the stokes radius and sedimentation co-efficient obtained from 
size exclusion chromatography and glycerol gradient centrifugation, the 
molecular mass for KIF1C-GFP was calculated using the formula 
M=4205×R×S (Erickson, 2009) (Table 18). 
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KIF1C-GFP RS (nm) S (S) M=4205×RS×S (kD) 
150 mM NaCl 5.8 9.8 239 
500 mM NaCl 6.4 8.1 218 
Table 18: Molecular mass calculation for KIF1C-GFP 
At 150 mM NaCl the stokes radius and sedimentation co-efficient were calculated to 
be 5.8 nm and 9.8 S, whereas at 500 mM NaCl it was found to be 6.4 nm and 8.1 S. 
From these values, the molecular mass was calculated to be around 239 kD and 218 
kD respectively. RS=Stokes radius, S=Sedimentation co-efficient. 
 
The predicted mass of a KIF1C-GFP monomer is 154 kD and 308 kD for a 
dimer. Using the hydrodynamic properties, our analysis suggests that KIF1C-
GFP is a dimer with a calculated mass of 239 kD at 150 mM and 218 kD at 
500 mM salt conditions. There was a difference in migration pattern that was 
observed at different salt conditions in size exclusion chromatography as well 
as glycerol gradient centrifugation. This suggested that the protein undergoes 
a transition to a different state. The frictional co-efficient determines if the 
protein is globular (1.2-1.3), slightly elongated (1.5-1.9) or very elongated (2-
3). This was calculated for KIF1C-GFP under different salt conditions that were 
tested (Fig 3.6). 
Figure 3.6: Frictional co-efficient of KIF1C-GFP 
The Smax/S ratio was calculated at increasing salt concentrations and plotted against 
different salt concentrations. Smax is the sedimentation co-efficient of the protein if it 
was a sphere. From the plot, it is evident that KIF1C-GFP becomes elongated with 
the increase in salt concentration. 
 
For KIF1C-GFP, it was observed that increasing the ionic strength 
increases the frictional co-efficient of the protein molecule from 1.5 to 2.0 (Fig 
3.6) suggesting a change from a folded to an extended form. From both 
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molecular mass calculations, it is likely that KIF1C-GFP is a dimeric motor 
protein that undergoes a conformation change to become more elongated at 
high salt concentrations. However, the deviations observed from the predicted 
molecular mass could be since the formula assumes the molecules to be a 
sphere and the kinesin motor proteins are not strictly spherical. An additional 
factor could be that since the glycerol gradient centrifugation was carried out 
in a high concentration of glycerol as opposed to size exclusion 
chromatography, this could influence the conformation state of the motor 
protein.  
The hydrodynamic analysis gave insight into the size and shape of 
KIF1C-GFP. It indicated that KIF1C-GFP is most likely dimeric in nature and 
might exist in a autoinhibited state in solution. To validate the folded 
autoinhibition state and to identify potential interaction sites between the tail 
and motor domain, cross-link mass spectrometry was employed. 
 
3.3. Cross-link mass spectrometry of KIF1C-GFP 
Cross-link mass spectrometry was carried out in collaboration with Hamdi 
Hussain (HH), McAinsh Lab, CMCB, University of Warwick. The reactions 
were setup in parallel with HH. The samples were run by the proteomics 
facility, University of Warwick using HH’s method. The analysis of the spectra 
was done together with HH. 
 
Cross-link mass spectrometry is a powerful tool to study protein interactions 
and to identify potential interaction surfaces (Rappsilber, 2011). To gain better 
understanding of the conformation state of KIF1C-GFP, cross-link mass 
spectrometry was performed with BS3 that crosslinks peptides in the vicinity 
of 11Å. KIF1C-GFP (500 nM) eluted with 50 mM sodium phosphate pH 7.5, 
150 mM NaCl, 150 mM imidazole, 0.1 mM ATP and 10% glycerol with a final 
pH of 8.5 was mixed with 5 mM of BS3 (bis (sulpho- succinimidyl) suberate) 
and in-solution cross-linking and digestion was carried out as described in the 
Methods section. 
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The cross-linked peptides were screened on the basis of a high score and 
good fragmentation. The b ions extend from the amino terminus and the y ions 
extend from carboxy terminus. A peptide is designated as an a peptide based 
on the fragmentation observed between the two cross-linked peptides. Higher 
fragmentation peptides are labelled as a whereas the lower fragmented 
peptide is labelled b. Scoring is achieved based on the observed 
fragmentation ions. A score of at least 100 is used as a cut-off which is based 
on the following, (a) Fragmentation ion series, which should be observed for 
both peptides, specifically those fragment ions that include the cross-linker 
and the attached second peptide. (b) Observed fragmentation ions should be 
within ~20 ppm of expected fragment ions and there should be 3 or more ion 
fragments for b or y ions in the a peptide. (c) Fragmentation ions observed 
should account for most of the high intensity peaks present in the spectra. 
There should only be a few unidentified high intensity signals in the spectra. 
(c) There should be little noise in spectra. 
A representative spectrum obtained for a cross-linked peptide IVmGK-
LKEGANINK for KIF1C-GFP shows the precursor ion in green which was 
fragmented well (reduction in relative intensity), b and y ions colour coded for 
the two peptides observed (Fig 3.7). 
Figure 3.7: Fragmentation spectra of a cross-linked peptide in KIF1C 
For the cross-linked peptide IVmGK-LKEGANINK, the precursor ion is shown in 
green, the peaks are labelled in colour and the b and y-ions are labelled with the 
peptide fragment name. 
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Figure 3.8: Primary structure of KIF1C showing crosslinks 
Crosslinks with a high threshold identified using BS3 (pink) are depicted in the primary 
structure of KIF1C along with sequence conservation between KIF1 family 
 
On the basis of the score and fragmentation state, there were three 
cross-links that were identified with high confidence. These are shown in Fig 
3.8 as pink arches for BS3 cross-links. Also shown is the sequence 
conservation of the peptides between other KIF1 family members KIF1A and 
KIF1B. 
One of the cross-links that was identified was Lysine 645 in the peptide 
641LEMEKR646 of the third coiled coil region (CC3), which made contact with 
Lysine 464 of the peptide 462LRKTEALR469 in the second coiled coil region 
(CC2). The CC2 region has been reported to fold back and disrupt motor 
activity in KIF1A (Hammond et al., 2009). Similarly, the other two cross-links 
(588IVmGK591 in the FHA domain and 641LEMEKR646 in the CC3 region) make 
contacts with Lysine 273 in the peptide sequence 265LKEGANINK273 in loop 
11 in the motor domain. This sequence is highly conserved between the KIF1 
family. Previously it has been reported that Lysine 266 from the 
265LKEGANINK273 peptide is essential for the increased processivity in KIF1A 
family motors (Scarabelli et al., 2015). From the structure (Fig. 3.9) it is evident 
that Lysine 266 makes contacts with the microtubule surface and blocking this 
site with the tail could potentially keep the motor in an autoinhibited state. 
Taken together, these results suggested that KIF1C exists in an autoinhibited 
tail-block state. 
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Figure 3.9: Structure of Kinesin-3 motor domain binding to the microtubule 
Residues of the kinesin motor domain (blue) that are known to contribute to the 
interaction with microtubules (grey) are shown in pink (Scarabelli et al., 2015) and the 
residue K273 shown to crosslink with the KIF1C tail is highlighted in magenta. PDB 
accession numbers: 4UXP. Adapted from (Siddiqui and Straube, 2017). 
 
3.4. Cross-link mass spectrometry with KIF1C-GFP and PTPN21 FERM 
 The KIF1C-GFP cross-links support the idea that the motor protein is 
in an autoinhibited tail-block state. To test whether the addition of FERM 
domain of PTPN21 would activate KIF1C, PTPN211-381 was purified from E. 
coli and cross-link mass spectrometry was performed with the two proteins. 
 
3.4.1. PTPN21-FERM purification 
 PTPN211-381 which is the FERM domain of PTPN21 was expressed in 
E. coli BL21 DE3 with an amino-terminal HA tag and a carboxy-terminal 6His 
tag. Purification was carried out in a two-step process with anion 
chromatography followed by affinity chromatography similar to KIF1C-GFP 
purification. The protein was visualized on SDS-PAGE as a 46 kD protein (Fig 
3.10). 
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Figure 3.10: Purification of PTPN21 FERM domain 
(a) Coomassie gel of HA-PTPN211-381-6His after anion exchange chromatography. 
The lysate was bound to SP-Sepharose beads and the column was washed with 
wash buffer containing 50 mM NaCl and eluted with 200 mM NaCl. Elutions E2-E5 
were pooled and bound to Ni-NTA beads for affinity chromatography. (b) Coomassie 
gel of HA-PTPN211-381-6His after affinity column purification. The elutions E2-E5 from 
SP-Sepharose were bound to Ni-NTA beads which was washed with 20 mM 
Imidazole containing wash buffer and eluted with 150 mM Imidazole. Elutions E2-E6 
were stored and used for subsequent experiments. 
 
3.4.2. Crosslink mass spectrometry with KIF1C-GFP and PTPN211-381 
KIF1C-GFP and PTPN211-381 were mixed in equimolar amounts and 
5 mM of the cross-linker BS3 and 5 mM of EDC were added in separate 
reactions and in-solution cross-linking was carried out as described in the 
Methods section. 
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Figure 3.11: Primary structure of KIF1C and PTPN21 showing cross-links 
Cross-links identified between KIF1C and PTPN211-381 are depicted in pink for BS3 
and in black for EDC. Sequence numbers in red represent PTPN21 and sequence 
numbers in black represent KIF1C. 
 
From the spectra and the fragmentation score, there were cross-links that 
were identified between KIF1C-GFP and PTPN211-381 which validated the 
binding of the two proteins (Fig.3.11). This is consistent with reports published 
previously which identified the region between 362 and 1103 of KIF1C binding 
to FERM domain of PTPN21 in a yeast two hybrid screen (Dorner et al., 1998). 
The peptide 588IVmGK591 in the FHA domain of KIF1C which crosslinked with 
the motor domain along with other tail cross-links of KIF1C to keep the motor 
in an autoinhibited state, was observed to make links with 301HKFYR305 
sequence from the FERM domain. The lack of KIF1C-GFP specific cross-links 
that were observed previously and the new cross-links with the FERM domain 
of PTPN21 suggests that the binding of PTPN21 could possibly relieve the 
autoinhibition. However, the crosslink mass spectrometry has been performed 
only once, repetitions with varying concentrations of the KIF1C and PTPN21 
FERM domain are required to validate these interactions. 
 
3.4.3. Ionic strength of different buffers 
 The final pH and ionic strength of the different buffers used in this study 
are listed below. The hydrodynamic analysis was carried out in 35 mM sodium 
phosphate buffer pH 7.5 with 1.5 mM MgCl2 at different salt concentrations 
between 150 and 500 mM NaCl whereas the cross-linking mass spectrometry 
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was performed with protein eluted in 50 mM sodium phosphate buffer pH 7.5, 
150 mM NaCl and 150 mM Imidazole, with a final pH of 8.5. It is important to 
note that the buffer composition is different between the two techniques and 
our results suggest that changes in salt concentrations affect the conformation 
state of KIF1C. It is important to carry out experiments in the low salt conditions 
in which KIF1C was observed to be in a folded state and the cross-link mass 
spectrometry data is consistent with this result. It would also be interesting to 
perform cross-link mass spectrometry at high salt conditions in which the 
protein adopts an elongated conformation as observed by glycerol gradient 
centrifugation. 
Buffer pH Ionic strength 
Ni-NTA elution buffer 8.5 0.36 
   
Size exclusion chromatography 150 mM NaCl 7.5 0.25 
                                                   500 mM NaCl 7.2 0.60 
   
Glycerol gradient centrifugation 50 mM NaCl 7.5 0.17 
                                                    150 mM NaCl 7.5 0.27 
                                                    250 mM NaCl 7.5 0.37 
                                                    350 mM NaCl 7.5 0.47 
                                                    500 mM NaCl 7.5 0.62 
   
Cross – link mass spectrometry 8.5 0.37 
Table 19: Ionic strength of different buffers 
The ionic strength of the various buffers used was calculated using the formula I = ½ 
S cizi2, where ci is the molar concentration of the ion and zi is the charge. The pH was 
measured after all components were added. 
 
3.5. Single-molecule behaviour of KIF1C 
To confirm that the FERM domain of PTPN21 activates KIF1C, the 
single molecule behaviour of KIF1C-GFP was characterized first and 
subsequently experiments with PTPN21-FERM were carried out using total 
internal reflection microscopy (TIRF). Single molecule motility assay with 
KIF1C-GFP on Hilyte647-labelled microtubules showed that KIF1C is a 
processive, plus-end accumulating motor (Fig 3.12). 
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Figure 3.12: KIF1C-GFP accumulates at plus-ends of microtubules 
KIF1C-GFP was added to a chamber with microtubules (MT) immobilised on a glass 
surface. KIF1C was observed walking to the plus-ends of the microtubules Arrow 
heads indicate KIF1C-GFP accumulation at microtubule plus-ends. KIF1C is in green 
and microtubules in magenta. 
 
3.5.1. Buffer optimisation 
 It is known from the literature that kinesin motors are sensitive to salt 
concentrations (Gilbert et al., 1995, A et al., 2014, Ma and Taylor, 1995, Vale, 
1996). To determine the optimal buffer condition for single molecule motility of 
KIF1C-GFP, various salt concentrations were tested and the velocities and 
run lengths were calculated for comparison. 
Single molecule motility assay was first carried out in MRB80 buffer without 
the addition of any extra salt. From the Fig 3.13 (a) the velocity and run length 
of the motors was found to be 0.51 µm/s and 1.9 µm respectively. All motors 
were found to bind the microtubules. With the increase of salt concentration to 
25 mM there was no significant change in velocity and run length (0.48 µm/s 
and 1.9 µm respectively Fig 3.13 (b)) but there was a reduction in the number 
of static/dead motors observed. With another step increase with KCl 
concentration to 50 mM, there was an increase observed in the velocity but no 
significant difference in run length of the motors (0.74 µm/s and 1.8 µm 
respectively (Fig 3.13 (c)). There was a further reduction in the number of 
motors binding and with the final increase to 75 mM KCl in the assay, there 
were very less binding events observed (Fig 3.13 (d)). From these data, the 
optimal buffer condition was chosen as MRB80 with the addition of 25 mM 
KCl. 
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Figure 3.13: Buffer optimization for KIF1C 
Kymographs and histogram of velocity and run length distributions depict effect of 
different salt concentration on the processivity and run length of KIF1CGFP. Image 
acquisition was at 2 fps. 
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3.5.2. Photobleaching of KIF1C  
 On the KIF1C-GFP kymographs, there were bright and dim runs 
observed. To address the heterogeneity in the assembly state of KIF1C, photo 
bleaching was carried out in the presence of AMP-PNP to lock the motors on 
the microtubules and to determine the oligomeric status of the pool of motors 
used in single molecule motility assay. 
Figure 3.14: Photo Bleaching of KIF1C 
Photo bleaching was carried out with KIF1C-GFP in a single molecule assay. (a) 
Representative kymograph and line plot showing the decrease in intensity over time. 
(b) Bar plot represents steps determined manually in orange and the best fit of a 
dimer/tetramer mixed binomial simulation in grey. d2 is the sum of squared deviations, 
x is the fraction of tetramer and p is the fraction of fluorescently active GFP. Data 
represents three different movies analysed. n=108 motor traces. The R code for 
mixed binomial model was written by Dr. Masanori Mishima. 
 
The intensity of KIF1C-GFP was measured over time then bleach steps were 
determined manually. A mixed binomial fit was performed on the bleach step 
distribution. The best fit is obtained if assuming a dimer to tetramer ratio of 7.8 
and a fraction of inactive GFP fluorophores of 20.8%. That only 80% of GFP 
fluorophores are functional is in line with findings by others (Ulbrich and 
Isacoff, 2007). The data represented here indicate that the oligomeric state of 
KIF1C-GFP is not uniform, but the majority of motors in the preparation is 
dimeric with a small population of motors in a higher order assembly state. 
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3.6. Ezrin-FERM purification 
In order to account for a control FERM domain in single molecule 
motility assays with KIF1C, the FERM domain of Ezrin was cloned and 
expressed in E. coli BL21 DE3 with an amino-terminal HA tag and a carboxy-
terminal 6His tag. Purification was carried out in a two-step process with anion 
chromatography followed by affinity chromatography similar to PTPN211-381 
purification. The protein was visualized on SDS-PAGE as a 41 kD protein (Fig 
3.15). 
Figure 3.15: Purification of Ezrin-FERM domain 
(a) Coomassie gel of HA-Ezrin1-328-6His after anion exchange purification. The lysate 
was bound to SP-Sepharose beads and the column was washed with 50 mM NaCl 
and eluted with 200 mM NaCl. Elutions E1-E7 were pooled and bound to Ni-NTA 
beads for affinity chromatography. (b) Coomassie gel of HA-Ezrin1-328-6His after 
affinity column purification. The input from SP-Sepharose was bound to Ni-NTA 
beads which was washed with 20 mM Imidazole Bacterial Ni-NTA Buffers and eluted 
with 150 mM Imidazole. Elutions E2-E6 were stored and used for subsequent 
experiments. 
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3.7. Single molecule assays with KIF1C-GFP, PTPN21-FERM and 
Ezrin-FERM 
 Single molecule motility assay was performed with KIF1C-GFP in the 
absence and presence of PTPN21-FERM and Ezrin-FERM. KIF1C-GFP was 
incubated with 125 nM of PTPN21-FERM or Ezrin-FERM for 15min before 
adding the rest of the motility mix (Table 17) and flowing into the chamber. In 
the control chamber with KIF1C-GFP alone, the elution buffer of PTPN21-
FERM/Ezrin-FERM was added and incubated for 15min to correct for any 
buffer effects. Representative kymographs are shown below for KIF1C-GFP, 
KIF1C-GFP + PTPN21-FERM and KIF1C-GFP + Ezrin-FERM (Fig 3.16). 
From the kymographs, the motors were scored as running if they moved with 
a velocity greater than 25 nm/s (green) or static - which did not move for the 
duration of the movie (grey). Runs with pause events or significant changes in 
speed were analysed as separate phases. Blind analysis was also carried out 
independently for an unbiased scoring of the data sets. 
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Figure 3.16: Single molecule motility assay with KIF1C-GFP, PTPN21-FERM 
and Ezrin-FERM 
The movies were imaged at 10fps. Representative kymographs for (a) KIF1C-GFP 
alone, (b) with the addition PTPN21-FERM and (c) with Ezrin-FERM depict runs in 
green and static motors in grey and landing events in orange. 
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Figure 3.17: Frequency of running motors 
The frequency of running motors is shown. Bar plots show mean±SEM from data 
pooled from three independent experiments. n=22-31 microtubules / 413-473 motors. 
Statistical significance (t-Test): *p<0.05. P21F: PTPN21-FERM, EzF: Ezrin-FERM. 
 
It is evident that there is an increase in the number of motors landing with the 
addition of PTPN21-FERM domain. The quantification of the frequency of 
running motors per microtubule length per minute revealed that KIF1C alone 
has a frequency of 0.15±0.01 µm-1min-1 whereas the addition of PTPN21-
FERM domain leads to a ~1.4fold increase (0.22±0.01 µm-1min-1) in the 
frequency of running motors observed. However, addition of Ezrin-FERM to 
KIF1C did not have a significant effect on the frequency of running motors 
(0.18±0.01 µm-1min-1). These data suggest that addition of PTPN21-FERM to 
KIF1C does indeed activate it thereby increasing the frequency of running 
motors. To probe deeper to determine if the addition of PTPN21-FERM 
domain increases the number motors landing or affects the interaction of 
KIF1C with microtubules, the landing rates and dwell times were calculated. 
  
  
 
64 
Figure 3.18: Landing rates and Dwell time. 
The landing rates and dwell times are shown as bar plots with mean±SEM. Data 
pooled from 3 independent experiments. n=22-31 microtubules / 413-473 motors. 
Statistical significance (t-Test): * p<0.05, ** p<0.005, *** p<0.0005. P21F-PTPN21-
FERM, EzF-EzrinFERM. 
 
To quantify the landing rates, all the motors that landed depicted as orange 
dots in Fig 3.17 were counted and normalised to microtubule length and 
observation time. There was a significant increase of about ~1.4 fold in the 
landing rate of KIF1C motors to the microtubule when PTPN21-FERM domain 
was present (Fig 3.18). The landing rate of KIF1C alone was 2769±244 s-1m-
1 which increased to 3998±379 s-1m-1 with PTPN21-FERM domain but not with 
Ezrin-FERM (3084±265 s-1m-1). The dwell times however did not show a 
significant difference between KIF1C (47.9±1.8 s) and PTPN21-FERM domain 
(45.6±1.7 s). The addition of Ezrin-FERM increased the dwell time significantly 
(53.9±2.1 s). These data suggest that PTPN21-FERM activates KIF1C and by 
virtue of this, there are more motors landing onto the microtubules. The data 
has been quantified by means of a blind analysis independently and has been 
repeated with different protein preparations and the results observed are 
consistent suggesting that indeed PTPN21-FERM domain activates KIF1C 
motors.  
Next, to determine if PTPN21-FERM domain influenced the velocity or run 
length of KIF1C, the distributions for the same were plotted as shown in Fig 
3.19. Addition of PTPN21-FERM or Ezrin-FERM did not have an effect on the 
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velocity but there was a reduction in the run length distributions of KIF1C. The 
run length decreased from 8.6±0.4 µm for KIF1C to 7.5±0.3 µm in the 
presence of PTPN21-FERM domain and to 7.8±0.3 µm with Ezrin-FERM. 
Figure 3.19: Velocity and Run length profile 
Histograms depict velocity and run length for KIF1C in grey and KIF1C with PTPN21-
FERM in orange and KIF1C plus Ezrin-FERM in green. The mean±SEM values are 
indicated for each condition. 
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Theoretically, the velocity profiles follow a Gaussian distribution and the run 
length follows an exponential decay (Vu et al., 2016). However, for 
superprocessive, truncated kinesin-3 motors normal distributions have been 
reported for both velocity and run lengths (Soppina et al., 2014). In our data, 
we frequently observe static and very slow motors. While static motors were 
excluded from the velocity analysis, the many slow motors result in an 
exponential distribution for the velocities. The prevalence of slow motors might 
be due to the presence of the tail that could interfere with motility. In gliding 
assays, a truncated version of KIF1C containing amino acids 1-679 showed 
fast motility of 2.0 ± 0.2 µm/s (Rogers et al, 2001). The distribution was normal 
similarly to other truncated kinesin-3 motors reported in the literature (Soppina 
and Verhey, 2014). The KIF1C run length could be exponential in nature if one 
considers that detecting very short runs (<500 nm) is difficult and thus likely to 
be underrepresented in the dataset. However, two limitations restrict the 
measured run length in these assays: the length of the microtubules (typically 
~10-15 µm) restricts detection of long runs and many of the slow-moving 
motors were present for the entire duration of the 3 min movie, suggesting that 
also the timing might restrict run length. The data presented have not been 
corrected for these effects. Thus, further experiments with increased 
microtubule length (20-30 µm) are required to validate the data. 
 
3.8. Conclusion 
The data observed here reveal that KIF1C is a dimer in solution in a 
possibly compact state and elongates at high salt concentrations. This is 
similar to kinesin-1 conformation change in which the motor protein transitions 
from 9 S to 6 S as the ionic strength increases (Hackney et al., 1992). For 
kinesin-1, a small peptide region in the tail of kinesin-1 binds to the motor 
domain to inhibit it (Friedman and Vale, 1999, Stock et al., 1999, Coy et al., 
1999). Crystal structure of kinesin-1 dimeric motor heads reveals a “double 
lockdown” mechanism where the movement of the motor heads is restricted 
due to the cross-linking at the coiled coil region and tail domains (Kaan et al., 
2011). Similarly, for KIF1C, cross link mass spectrometry validated the 
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compact state by the cross links that were observed between the tail and 
motor domain. Addition of PTPN21-FERM domain relieves the autoinhibition 
and activates the pool of motors, similar to the activation of kinesin-1 by JIP-3 
(Watt et al., 2015, Sun et al., 2011). 
Taken together, these data suggest that KIF1C is a dimer in solution 
and the PTPN21-FERM domain does indeed activate KIF1C as shown by the 
frequency of running motors and the landing events. Binding of PTPN21-
FERM domain relieves the tail-block autoinhibition of KIF1C and the motor can 
now step along microtubules and/or bind cargo and more active motors are 
observed moving on the microtubules. 
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Chapter 4 REGULATION OF KIF1C ACTIVITY IN CELLS 
 
4.1. Disrupting the tail-motor interaction results in a hyper active 
KIF1C 
In cells, motor activity is tightly regulated in the absence of cargo by 
keeping it in an autoinhibited state to avoid microtubule crowding and futile 
ATP consumption (Verhey et al., 1998). The results in Chapter 3 suggest that 
KIF1C exists in an autoinhibited tail-block state which is activated by the 
binding of the phosphatase PTPN21. To test if disrupting the tail-motor 
interaction sites relieves the autoinhibition and creates a dominant active 
KIF1C, the tail regions that made contacts with the motor domain based on 
cross-linked mass spectrometry data were mutated and/or deleted. The 
substitutions made were designed to hinder the interactions either by charge 
reversal mutations, substitution with alanine or deletion of domains (Fig 4.1). 
It is important to note that the amino acids selected for substitutions were 
based on the cross-link mass spectrometry data alone. It is possible that the 
actual interaction surface is quite far away in the primary sequence. 
Figure 4.1: KIF1C deletion and mutation constructs  
Primary structure of KIF1C depicting deletion (dotted line) and mutation (blue 
asterisk) constructs generated based on cross-link mass spectrometry links identified 
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in Chapter 3 (pink arches). Arg463 and Lys464 in the second coiled coil region were 
mutated to Ala and Glu respectively to generate KIF1CR463AK464EGFP. Lys591 in the 
FHA domain was mutated to Glu to generate KIF1CK591EGFP and Glu642, Glu644 
and Lys645 in the third coiled coil region were mutated to Ala to generate 
KIF1CE642AE644EK645AGFP. The third coiled coil deletion constructs KIF1CD623-D679GFP 
and were KIF1CD623-D825GFP were already available in lab. 
 
In Retinal pigmented epithelial (RPE) cells, KIF1C accumulates dynamically 
at the tip of the tail and delivers the fibronectin receptor a5b1-integrin into the 
cell tail which is required for the maturation of trailing adhesions and 
maintenance of cell tails (Theisen et al., 2012). We used the tail accumulation 
of KIF1C as a read out for motor activity. We co-expressed KIF1C-mCherry 
and KIF1C-GFP in RPE cells. The quantification of the mean enrichment of 
KIF1C at the tail and the front relative to cytoplasmic levels reveal that both 
mCherry and GFP tagged full-length KIF1C constructs accumulate to a similar 
extent but there is a higher level of accumulation observed at the tail than the 
front (Fig 4.2a). Hence, we used this assay to determine the activity of the 
mutants and deletions in comparison to full-length KIF1C-mCherry. 
Figure 4.2: KIF1C localisation in RPE cells  
(a) RPE cells were co-transfected with KIF1C-mCherry and KIF1C-GFP and imaged 
24hr post transfection. KIF1C accumulates at the tip of the tails. Images were 
adjusted using ImageJ to similar cytoplasmic background. The calibration bar 
represents the intensity profile for the images. (b) Line series represents ratio of 
accumulation of KIF1C measured in the tail versus cytoplasm. (c) Box plot depicts 
ratio of KIF1C accumulation relative to cytoplasmic levels, measured in GFP versus 
mCherry channels at the tail and at the front. Green line represents the median. Data 
pooled from three independent experiments, n=26-98. 
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To assess accumulation of mutants, RPE cells were co-transfected with 
KIF1C-mCherry and the deletions or mutations with a GFP tag. Cells were 
imaged 24 hr post transfection. Image analysis revealed that most of the cells 
lacked tails in the deletion constructs and were round in shape (Fig 4.3 a). For 
comparison, similar shape cells were chosen for KIF1C-mCherry 
quantification. Both the deletions, KIF1CD623-D679GFP and KIF1CD623-D825GFP 
localized towards the periphery and the quantification of mean accumulation 
of the “accumulation peaks” revealed higher accumulation of the deletion 
constructs (3.6±0.58 and 3.9±0.65) than that observed for full length-KIF1C 
(1.3±0.04) albeit the full-length protein is delocalized (presumably by 
dimerization with the truncated constructs) and accumulates without a rear 
bias. This suggests a hyperactive phenotype for the deletion constructs. 
Subsequently, unpublished data from the Straube lab (Zwetsloot et al., 
unpublished) show that the cells transfected with deletion constructs make 
tails and the tail to cytoplasm ratio was found to be increased for the KIF1C 
deletion constructs in comparison to wildtype. This is consistent with the data 
observed here. 
Next, RPE cells were co-transfected with KIF1C-mCherry and the mutations 
KIF1CR463AK464EGFP, KIF1CK591EGFP and KIF1CE642AE644AK645AGFP. Image 
analysis and quantification of mean accumulation at the rear and the front 
revealed that the mutation R463A and K464E in the second coiled coil region 
resulted in dramatically increased accumulation in the tail (6.7±0.8) and the 
front of the cell (6.4±0.8). The FHA domain mutation K591E led to a slight 
increase in accumulation (2.2±0.1 at the tail and 1.6±0.1 at the front). The triple 
mutant in the third coiled coil domain did not show a significant difference in 
accumulation (1.4±0.1 and 1.3±0.04 at the rear and front) in comparison to wt 
KIF1C (1.3±0.04 and 1.2±0.04 at the rear and front) (Fig 4.4a).  
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Figure 4.3: Enrichment of KIF1C-deletion constructs 
(a) RPE cells were co-transfected with full-length KIF1C-mCherry and deletion 
constructs tagged with GFP and imaged 24hr post infection. Images were adjusted 
using ImageJ to similar cytoplasmic background. The calibration bar represents the 
intensity profile for the images. (b) Line series represents ratio of KIF1C measured in 
the accumulation peaks versus cytoplasm. (c) Box plot depicts ratio of KIF1C relative 
to cytoplasmic levels, measured in GFP versus mCherry channels at the 
accumulation peaks. Green line represents the median. Orange line represents the 
wt level for reference. Data pooled from three independent experiments, n=17-38. 
Statistical significance (t-Test): *** p<0.0005. 
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Figure 4.4: Enrichment of KIF1C mutation constructs 
(a) RPE cells were co-transfected with KIF1C-mCherry and KIF1C-mutation 
constructs and imaged 24hr post transfection. Images were adjusted using ImageJ 
to similar cytoplasmic background. The calibration bar represents the intensity profile 
for the images. (b) Line series represents ratio of accumulation of KIF1C measured 
in the tail versus cytoplasm. (c) Box plot depicts ratio of accumulation relative to 
cytoplasmic levels, measured in GFP versus mCherry channels at the tail and front. 
Green line represents the median. Orange line represents the wt level for reference. 
Data pooled from three independent experiments, n=26-48. Statistical significance (t-
Test): *p<0.05. RK- R463AK464E, K- K591E, EEK- E642AE644AK645A. 
 
Deleting the entire third coiled coil region or the point mutations in the second 
coiled coil region of KIF1C both of which have been shown to interact via 
cross-link mass spectrometry, resulted in higher accumulation of the 
constructs at the tail and the front of the cell. This phenotype suggests 
hyperactivity of the motor protein and indicates that in the absence of the third 
coiled coil domain interacting with the motor domain and second coiled coil 
region, the motor domain is free to make contacts with the microtubule surface 
and is no longer held in an autoinhibited state. Alternative explanations to 
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hyperactivity would be that the observed increase in accumulation is due to a 
higher retention of the mutant constructs at microtubule plus-ends or a 
decrease in minus-end transport due to the inability to bind an adaptor protein. 
Either of those would also results in the motors accumulating to a greater 
extent than wildtype KIF1C at the edge of the cell without the requirement of 
the motors moving more or faster. 
 
4.2. The Proline-rich region is required for KIF1C localisation in cells 
For KIF1C to accumulate at the tip of the tail in migrating cells, but not 
everywhere at the periphery, it either needs to have a bias to the rear or be 
retained specifically at the tail tip. It could be possible that KIF1C is anchored 
at microtubule plus ends in the rear by interactions with other proteins 
exclusively present in the rear of the cell. Thus, KIF1C would walk to all 
microtubule ends but is specifically retained at the cell rear. To determine the 
structural domains of KIF1C contributing to the rear accumulation in cells, 
various truncations of KIF1C were tested for their ability to accumulate at the 
tip of the tails in RPE cells in comparison to full-length KIF1C. 
The series of truncations that were available in lab were used for this purpose 
- KIF1C1-490GFP which is a minimal construct with the motor domain and two 
coiled coils, KIF1C1-610GFP which includes regions until the end of the FHA 
domain, KIF1C1-822GFP further includes the third coiled coil and KIF1C1-
912GFP includes the fourth coiled coil domain. In addition to these constructs, 
KIF1C1-950GFP which lacks the proline-rich region and KIF1C1-1043GFP which 
lacks the binding regions of Rab6 and 14-3-3 proteins were generated. 
Truncation sites were chosen considering database predictions of coiled-coil, 
globular regions and unstructured regions – the latter were used for positioning 
truncations to minimise the probability of misfolding of the resulting protein (Fig 
4.5). 
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Figure 4.5: Primary structure of KIF1C truncations  
KIF1C was truncated at various positions in unstructured regions in the C-terminal 
tail region to identify the structural domains contributing to the rear accumulation in 
cells. 
 
RPE cells were co-transfected with full-length KIF1C-mCherry and truncated 
KIF1C-GFP constructs to determine the localisation phenotypes of the 
different truncations in comparison to full-length KIF1C. Previous reports from 
our lab have shown that KIF1C localises at the tip of the tail in migrating cells 
and is important for directional persistence in these cells (Theisen et al., 2012). 
The co-transfection of wildtype KIF1C is important since the status of the tail 
determines how much KIF1C accumulates - forming tails show increase in 
KIF1C accumulation and retracting tails show a rapid decrease in KIF1C 
accumulation (Theisen et al., 2012). Thus, KIF1C-mCherry serves as an 
internal control for the tail state. Image analysis and quantification of mean 
accumulation at the rear or front and in cytoplasm revealed differences in the 
localization pattern of the KIF1C truncations in comparison to full-length motor. 
For comparison, we also measured accumulation at the front of the cell. 
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Figure 4.6: Co-localisation of full-length KIF1C and KIF1C-truncations 
(a) RPE cells were co-transfected with full-length KIF1C-mCherry and KIF1C-
truncation-GFP and imaged 24hr post transfection. Images were adjusted using 
ImageJ to similar cytoplasmic background. The calibration bar represents the 
intensity profile for the images. (b) Line series represents ratio of accumulation of 
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KIF1C measured in the tail versus cytoplasm and front versus cytoplasm. (c) Box plot 
depicts ratio of accumulation relative to cytoplasmic levels, measured in GFP versus 
mCherry channels at the tail and front. Green line represents the median. Orange line 
represents the wt level for reference. Data pooled from three independent 
experiments, n=10-98. Statistical significance (t-Test): *p<0.05. 
 
The KIF1C1-490GFP construct was found to be mainly in the cytoplasm (Fig 
4.6a). The tail and front accumulation was significantly reduced to 10% of the 
full-length motor. This construct comprises of the motor domain along with the 
two coiled coils only. But, since we find this construct to be mainly cytosolic, it 
suggests that the domains in the tail are indeed required for proper localisation 
of KIF1C in the cell. 
The KIF1C1-610GFP construct which includes the tail until the FHA domain was 
seen decorating microtubules throughout the cell (Fig 4.7). But, it did not co-
localize with full-length KIF1C very well and was excluded from regions where 
full-length KIF1C was present. 
Figure 4.7: KIF1C1-610GFP decorates microtubules 
RPE cells co-transfected with KIF1C-mCherry and KIF1C1-610GFP. Microtubule 
decoration was observed in KIF1C1-610GFP (inset). 
 
The KIF1C1-822GFP construct localizes to the nucleus and does not 
accumulate in the tail (0.1±0.01) or front (0.1±0.01). This truncation possesses 
the FHA domain along with the PTPN21 and Myosin IIA binding site. Upon 
closer inspection, there is a predicted nuclear localisation signal identified near 
the truncation site which might become exposed in the truncation and explain 
the mislocalization. 
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The KIF1C1-912GFP and KIF1C1-950GFP constructs which exclude the proline-
rich region as well as 14-3-3 and Rab6 binding regions localize to the rear and 
front to some extent, but not as strongly as the full-length. Finally, with the 
inclusion of the proline-rich region in the construct KIF1C1-1043GFP there was 
complete co-localisation observed (1.2±0.1) between full-length KIF1C and 
the truncated construct at the tail and front with a higher accumulation at the 
tail. From literature it is known that the truncated motors are often dominant 
active since the tail is no longer present to interfere with the motor head to 
keep it in an autoinhibited state (Soppina et al., 2014, Hammond et al., 2009). 
But, the results observed here indicate that truncating the tail region of KIF1C 
results in a pool of motors that is mainly cytoplasmic. It remains to be seen in-
vitro if the 1-490 construct behaves as a dominant active motor. Although we 
set out to determine the structural regions contributing to rear accumulation, 
we found that truncating the tail region of KIF1C not only affects the tail 
localisation but the front localisation as well, suggesting that the proline-rich 
region is important for the activity of the motor to walk to the cell periphery 
rather than any specific retention or bias towards the rear. Further experiments 
are required to decipher how exactly the proline-rich region mediates the 
efficient localisation of KIF1C in cells. One possibility is that the cargo adapters 
and Rabs that bind in this region are keeping the motor in an active 
conformation. 
 
4.3. 14-3-3 proteins negatively regulate KIF1C activity 
 14-3-3 adapter proteins are known to regulate kinesin motor activity 
(Douglas et al., 2010, Yoshimura et al., 2010). These proteins recognize and 
bind to phosphoserine or phosphothreonine proteins, thereby regulating the 
kinesin motor activity (Fu et al., 2000, Tzivion and Avruch, 2002). For KIF13B, 
a kinesin-3 family member, it has been shown that the motor exists in an 
autoinhibited state (Yamada et al., 2007) and upon phosphorylation by 
Par1b/MARK2, which is a microtubule affinity regulating kinase, 14-3-3β binds 
and promotes the intramolecular interaction of KIF13B motor and tail domains. 
This in turn negatively regulates KIF13B microtubule binding, resulting in the 
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dispersal of the motor in the cytoplasm and a reduction in cell protrusion and 
axon formation (Yoshimura et al., 2010). 
 Figure 4.8: KIF1C deletion and mutation constructs 
KIF1C was truncated at various positions in unstructured regions in the C-terminal 
tail region to identify the structural domain contributing to the rear accumulation in 
cells. 
 
KIF1C has been shown to interact with 14-3-3 proteins in a yeast two-hybrid 
screen in a phosphorylation-dependent manner via the phosphorylation of 
Serine 1092 by an unknown kinase (Dorner et al., 1999) but the functional 
consequence of the binding of 14-3-3 proteins to KIF1C remains to be 
elucidated. To understand the physiological significance of the interaction 
between 14-3-3 proteins and KIF1C, Ser1092 was mutated to Alanine to 
disrupt the binding of 14-3-3 proteins and Ser1092 to Glutamate to generate 
a phosphomimetic mutant – although it is known that phosphomimetic 
mutations of 14-3-3 tend not to work and replicate the finding of 
nonphosphorylatable Alanine mutations (Johnson et al., 2010) (Figure 4.8). 
RPE cells were co-transfected with KIF1C-mCherry and the mutations 
KIF1CS1092AGFP and KIF1CS1092EGFP. Image analysis and quantification of 
the mean intensities at the rear and the front revealed that both point mutants 
accumulate at the tail (2.0±0.1 and 2.0±0.09) and the front (1.9±0.2 and 
1.5±0.09) of the cells to a greater extent than full-length KIF1C (Fig 4.9). This 
suggests that 14-3-3 binding is required to control the levels of KIF1C 
accumulation or motility in the cell via negative regulation. In the absence of 
this, there is higher accumulation observed. Thus 14-3-3 binding negatively 
regulates KIF1C accumulation or motility. 
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Figure 4.9: Enrichment of the 14-3-3 mutants at front and rear of the cell. 
(a) RPE cells were co-transfected with full-length KIF1C-mCherry and KIF1C-
mutants-GFP and imaged 24hr post transfection. Images were adjusted using 
ImageJ to similar cytoplasmic background. The calibration bar represents the 
intensity profile for the images. (b) Line series represents ratio of accumulation of 
KIF1C measured in the tail versus cytoplasm and front versus cytoplasm. (c) Box plot 
depicts ratio of accumulation relative to cytoplasmic levels, measured in GFP versus 
mCherry channels at the tail and front. Green line represents the median. Orange line 
represents the wt levels. Data pooled from three independent experiments, n=10-98. 
Statistical significance (t-Test): *p<0.05. 
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4.4. Conclusion 
The results discussed here suggest that the deletion of the third coiled 
coil domain results in a dominant active KIF1C which is consistent with the 
crosslink mass spectrometry data observed in Chapter 3 which show that the 
third coiled coil domain crosslinks with the second coiled coil and motor 
domain. In the absence of the coiled coil domains, the tail is no longer able to 
make contacts with the motor domain thereby making it dominant active. Using 
KIF1C truncations tagged with a GFP fluorophore it was found that the proline 
rich domain at the C-terminus of the motor protein is required for proper 
localization of KIF1C in cells. One of the limitations of this study is that the 
relative expression of mCherry-tagged wild-type and GFP-tagged mutants 
cannot easily be controlled for. However, based on Western blot analysis of 
our stable KIF1C-GFP cell line that expresses roughly comparable levels to 
endogenous protein (Theisen et al., 2012), we know how endogenous level 
localisation looks like and that expression above those levels results in 
aberrant, highly elongated cell shape and accumulation of KIF1C elsewhere 
in the cell. Thus, for data analysis, only low to medium expressing cells were 
selected and total cell levels were measured to control for relative expression 
levels (Table 20). The construct KIF1CR463AK464EGFP that resulted in massive 
accumulation was actually expressed less than the other GFP constructs 
suggesting that the accumulation phenotype observed is not due to higher 
expression. 
Total cell fluorescence, mean ± SD 
 KIF1C mCherry GFP 
KIF1C 9.3 ± 5.4 87.6 ± 45.6 
KIF1CR463AK464EGFP 11.5± 5.4 38.2 ± 19.7 
KIF1CK591EGFP 14.3 ± 10.0 51.6 ± 34.8 
KIF1CE642AE644AK645AGFP 15.4 ± 9.8 54.9 ± 36.0 
Table 20: Total cell fluorescence 
The total cell fluorescence levels were measured for different KIF1C constructs (n=11 
to 28). The mean ± SD are reported above. 
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Taken together, these results are consistent with a model whereby 
binding of PTPN21 activates KIF1C (Chapter 3) and 14-3-3 protein binding 
negatively regulates KIF1C activity. None of the truncation experiments 
showed a specific loss of tail accumulation while retaining enrichment at the 
periphery, suggesting that defects observed are likely due to reduced motor 
activity rather than interaction with a potential tail-specific interaction partner 
that mediates retention. The absence of this might suggest that tail retention 
is due to limited retrograde transport opportunities in the tail rather than 
specific retention. 
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CHAPTER 5 FORCE GENERATION AND PATIENT MUTANTS 
 
 Kinesin-3 mediated long-distance cargo transport is essential for 
cellular maintenance and function (Kern et al., 2013) (Otsuka et al., 1991). The 
motors transport cargo by walking along microtubules, converting the 
chemical energy generated by ATP hydrolysis into mechanical work (Chang 
et al., 2013, Cross, 2016). It is evident from literature that the kinesin-3 motor 
proteins can walk substantial distances before falling off from the microtubule 
track making them highly processive and particularly suited for long-distance 
transport (Soppina et al., 2014). A characteristic feature of these motor 
proteins is the presence of a stretch of positively charged lysine residues 
designated as the K-loop in the motor domain which has been shown to 
enhance microtubule binding (Soppina and Verhey, 2014) (Rogers et al., 
2001). Mutations identified in the motor domain of the KIF1 family members 
have been shown to cause neurological disorders, hereditary spastic 
paraplegia and cerebellar dysfunction in humans (Caballero Oteyza et al., 
2014, Erlich et al., 2011) (Dor et al., 2014). However, little is known about the 
force generation for kinesin-3 members and how the motor proteins respond 
to load in a normal and diseased condition. For truncated monomeric KIF1A, 
it has been shown that the motor moves by a biased Brownian motion in 8 nm 
steps against a load of up to 0.15 pN (Okada et al., 2003). To elucidate the 
single molecule mechanics of KIF1C and to probe the effect of the mutations 
identified in patients, optical trapping and single molecule motility assays were 
employed. 
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5.1. Optical Trap 
Optical trapping was carried out in collaboration with Dr. Algirdas Toleikis (AT), 
Cross Lab, CMCB, University of Warwick. Force generation experiments were 
performed together with AT and the analysis of the traces was done using 
code written by AT unless mentioned otherwise. The details of the optical trap 
used here were published previously by (Carter and Cross, 2005). 
 Optical traps use a highly-focussed laser beam to generate force in the 
order of piconewtons to be able to physically hold and move a dielectric 
particle - a polystyrene bead with a diameter of 560 nm in this case. The 
refraction of the infra-red laser by the polystyrene bead transfers momentum 
to the bead and tends to centre it in the beam, thereby creating a trapping 
potential. The same effect generates returning force whenever the bead is 
pulled off-centre by the attached motor protein. The further the motor walks 
away from the trap centre, the greater is the force experienced. The position 
of the bead is tracked and the motions of the motor under load inferred (Fig 
5.1). 
Figure 5.1: Optical Trap 
Schematic of a single kinesin motor attached to the bead. The motor displaces the 
bead from the centre of the trap while walking along microtubules (MT) immobilised 
on a glass surface. The bead’s position relative to the centre of the trap is recorded. 
Figure not to scale. 
 
5.1.1. Stepping behaviour of wildtype-KIF1C 
 Human KIF1C-GFP wildtype purified from insect cells described in 
Chapter 3 was used at concentrations such that less than 20% of the beads 
moved along microtubules. The Poisson distribution determines the probability 
of a given number of events occurring in a fixed interval of space or time 
(Ahrens and Dieter, 1974). In our optical trapping experiments, we observed 
that 20% of beads moved along the microtubules. This means, P (0), which is 
the probability of beads that do not move is 0.8. From P (0), the average 
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number of kinesins bound per bead (x) was calculated to be 0.2231 (Fig. 5.2). 
Based on this, the probability of a single dimeric motor bound to a moving 
bead was found to be 89% and that for more than 2 motors bound was 11% 
(Fig. 5.2). 
Figure 5.2: Poisson distribution 
Poisson distribution for the number of motors bound to the bead (k) is calculated for 
20% beads moving. The probability of a bead moving with 2 or more motors was 
found to be 11%. 
 
The trap was calibrated before the start of the experiment and from the traces 
generated, a step finding algorithm that uses a moving window t-test was used 
to detect steps (Fig 5.3 a) (Carter and Cross, 2005). From the traces collected, 
the step sizes for all detectable steps were plotted against force (Fig 5.3 b). 
Steps detection started at 1 pN force since the amplitude of any steps detected 
below this threshold would be close to that of system noise and therefore 
unreliable. At low force, the frequency of forward steps (blue) taken is higher 
and as the force (load) increases, it reduces. At 0 pN force, KIF1C-GFP was 
observed to walk processively with a velocity of ~550 nm/s along microtubules 
which is close to the single molecule results discussed in chapter 3. The mean 
step size for KIF1C-GFP from the forward step size distributions (Fig 5.4 a) 
was around 7.4 nm, which is close to the 8 nm spacing observed for squid 
kinesin head domain bound to the same microtubule protofilament (Song and 
Mandelkow, 1993) (Svoboda et al., 1993). However, the backward step size 
was distributed more broadly without any dominating step size (Fig 5.4 b). 
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Figure 5.3: KIF1C-GFP motor trace under the trap and detected steps 
(a) KIF1C-GFP wildtype was bound to 560 nm polystyrene beads and added to a flow 
cell with microtubules immobilised on the glass surface. Under the load of the trap, 
KIF1C-GFP walks along the microtubule and the trace recorded at 20 kHz and mean-
filtered to 1 kHz (1 ms) is shown in blue. Y-axis on the left shows distance moved. 
Time is on the X-axis and force experienced by the motor on the Y-axis is on the right. 
Horizontal grid lines are drawn 8 nm apart, depicting the expected step size. The 
steps detected using the step-finder are highlighted in orange. Parameters used in 
step finder algorithm - t-test score threshold=30, minimum step size=5 nm, minimum 
force=1 pN, moving average, n=20 (1 ms). (b) The sizes of all detected steps 
(n=1279) are plotted on Y-axis with the corresponding force experienced in 
piconewtons on X-axis. Forward steps are represented in blue, backward steps in 
orange. At higher forces, the motor is unable to make any more forward steps and 
falls back to the centre of the trap. This is known as a drop-off and is depicted in grey. 
If the motor re-attaches following a drop-off, we called this a slip, shown in green. 
 
Figure 5.4: Step size distributions of Forward steps and Backward steps 
From the steps detected, the relative frequency of forward steps (n=394). and 
backward steps (n=153) were plotted against step size (nm). The step size from the 
forward step distribution was found to be 7.4 nm for KIF1C-GFP. Data pooled from 
three independent experiments with two independent protein preparations. 
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5.1.2. Dwell times for wildtype-KIF1C 
 The dwell times represent the time between two consecutive steps 
taken by the motor - the time during which each motor domain remains bound 
to the microtubule between steps. Steps below 1 pN force were disregarded 
since the traces have high noise and steps cannot be assigned reliably. The 
dwell time for KIF1C-GFP at 2 pN was found to be 34 ms. As the load 
increases the dwell time was found to increase to 188 ms at 6 pN after which 
it plateaus. At 8 pN the dwell time dropped to 84 ms (Fig 5.5). This could be 
for at least two reasons. First, the number of data points at 8 pN is low and the 
error large. So, the reduction might not be significant and level out when more 
data are collected for example by moving the stage to push more motors into 
the high force regime. Secondly, only 2 out of the 37 traces contribute to the 
data points above 8 pN. It is possible that these two beads had two motors 
bound as from the Poisson distribution (Fig 5.2), the expected fraction of 
moving beads with two or more motors bound is 11%. It would be expected 
that for a pair of motors the dwell time would be shorter. To rule out this 
possibility, trapping assays need to be repeated with a lower rate of average 
kinesin per bead, i.e. a lower moving bead rate and high force data collected 
under conditions where high force is reached by moving the stage to above 
stall force levels. 
Figure 5.5: Dwell times for KIF1C-GFP 
The dwell times were determined from the steps detected and were manually verified 
for an authentic dwell event. The dwell times were plotted on a Y-axis (log scale) 
against force in piconewtons. Data points were binned every 1 pN and the standard 
error is represented in blue error bars. 
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5.1.3. Stall force for wildtype-KIF1C 
Stall force is the force experienced by the motor at which the probability 
of forward stepping is equal to that of backward stepping and there is no net 
forward movement observed. Stall force can be determined by plotting the 
ratios fore step : back step ratio versus load as shown in Fig 5.6. The stall 
force for KIF1C-GFP was found to be ~5.5 pN. 
Figure 5.6: Stall force for KIF1C-GFP 
Ratio of fore step and back step (log scale) on Y-axis is plotted against increasing 
force in piconewtons on X-axis. The error bars represent SE. The stall force is 
determined to be ~5.5 pN when the ratio of fore step to back step is 1, depicted by 
the intersection of the green and black line. 
 
5.1.4. Force-velocity curve for wildtype-KIF1C 
 At lower force the motor experiences least load and the velocity is 
highest. As the load is progressively increased, the velocity progressively 
decreases until the motor ultimately stalls. At 0 pN, the velocity of KIF1C was 
found to be ~550 nm/s. As the force (load) increases, the velocity starts to 
decrease and diminishes around 5-6 pN which is the maximum force 
experienced by the motor (Fig 5.7). 
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Figure 5.7: Force – velocity curve for KIF1C-GFP 
The velocity calculated from the slope of the linear fits (orange lines) at 20 nm trace 
intervals (inset) was plotted against force in piconewtons to generate a force-velocity 
curve. The MATLAB code to determine the velocity was written by Dr. Anup Das, 
School of Engineering, University of Warwick. 
 
5.2. HSP causing Patient Mutants identified in KIF1C 
Hereditary spastic paraplegia (HSP) is a genetic disorder characterised 
by the spasticity of lower limbs. Since kinesin-3 motors are implicated in long-
haul transport, this might explain why the lower limbs are preferentially 
affected in these patients. Mutations identified in two different families in 
KIF1C are present in the highly-conserved motor domain region (Fig 5.8). This 
could potentially affect the microtubule binding and ATP hydrolysis domains 
thereby hindering motor function. 
Exome sequencing of a family diagnosed with HSP revealed that the parents 
were carriers of mutations KIF1CPro176Leu and KIF1CGly102Ala (Caballero 
Oteyza et al., 2014). KIF1CPro176Leu lies in the motor domain and close to 
the microtubule interaction region whereas KIF1CGly102Ala is present in the 
highly-conserved nucleotide binding p-loop. KIF1CGly102Ala mutation 
renders the motor inactive keeping it in a rigor state (Dorner et al., 1998). The 
parents had one copy of wildtype and one copy of the mutation, but the 
offspring had both mutant variants expressed together which developed into 
a diseased condition. Previously reported studies using localisation 
phenotypes in COS-7 African green monkey cell lines reveal that wildtype 
KIF1C was able to rescue the perinuclear mislocalization of the mutant 
  
 
89 
KIF1CGly102Ala, but the mutant KIF1CPro176Leu protein does not rescue 
this defect, suggesting that pathogenicity occurs when these variants are 
expressed together, as observed in the patients (Caballero Oteyza et al., 
2014). Another mutation KIF1CArg169Trp that lies in the motor domain was 
identified by whole exome analysis in another family as a missense mutation 
(Dor et al., 2014) but functional studies are lacking. To gain a better 
understanding of these mutations and how they affect the motor’s ability to 
carry out long-distance transport, the two mutants KIF1CPro176Leu and 
KIF1CArg169Trp were chosen (Fig 5.8) for subsequent experiments. 
Figure 5.8: Structure of Kinesin-3 motor domain depicting HSP mutations 
Primary structure of KIF1C depicting the mutations P176L and R169W in the motor 
domain identified in HSP patients with sequence conservation between KIF1 family 
members. The mutations are highlighted in red. 
 
5.2.1. Purification of full-length KIF1C-GFPP176L 
 KIF1C-GFPP176L was expressed in SF9 insect cells with an amino-
terminal 6HIS tag and a carboxy-terminal GFP tag. Purification was carried 
out in a two-step process by anion exchange chromatography using SP-
Sepharose beads and affinity chromatography using Ni-NTA beads similar to 
the wildtype KIF1C-GFP. 
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Figure 5.9: Purification of full-length KIF1C-GFPP176L 
(a) Coomassie gel of 6His-KIF1C-GFPP176L after anion exchange chromatography. 
The lysate was bound to SP-Sepharose beads and the column was washed with 150 
mM NaCl and eluted with 300 mM NaCl. Elutions E1-E6 were pooled and bound to 
Ni-NTA beads for affinity chromatography. (b) Coomassie gel of 6His-KIF1C-
GFPP176L after affinity chromatography. The elutions E1-E6 from SP were bound to 
Ni-NTA beads and washed with 50 mM Imidazole and eluted with 150 mM Imidazole. 
Elutions E2 – E7 were stored for subsequent experiments. 
 
5.2.2. Purification of KIF1C-GFPR169W 
KIF1C-GFPR169W was expressed in SF9 insect cells with an amino-
terminal 6HIS tag and a carboxy-terminal GFP tag. Purification was carried 
out in a two-step process by anion exchange chromatography using SP-
Sepharose beads and affinity chromatography using Ni-NTA beads similar to 
the wildtype KIF1C-GFP protein. 
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Figure 5.10: Purification of full-length KIF1C-GFPR169W 
(a) Coomassie gel of 6His-KIF1C- GFPR169W after anion exchange chromatography. 
The lysate was bound to SP-Sepharose beads and the column was washed with 150 
mM NaCl and eluted with 300 mM NaCl. Elutions E1-E4 (E3-E4 not on gel) were 
pooled and bound to Ni-NTA beads for affinity chromatography. (b) Coomassie gel of 
6His-KIF1C- GFPR169W after affinity chromatography. The elutions E1-E4 from SP 
were bound to Ni-NTA beads and washed with 50 mM Imidazole and eluted with 150 
mM Imidazole. Elutions E3 – E7 were pooled and stored for subsequent experiments. 
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5.2.3. Single molecule behaviour 
To establish the effect of the mutations on the motor protein and to determine 
if the mutations interfere with the ability of the motor protein to walk single 
molecule motility assays were performed with labelled microtubules 
Figure 5.11: KIF1C patient mutants accumulate at plus-ends of MTs 
(a) KIF1CP176L (b) KIF1CR169W was added to a chamber with microtubules (MT) 
immobilised on a glass surface. Both KIF1C patient mutants were observed moving 
to the plus-ends of the microtubules. Arrow heads indicate KIF1Cmut accumulation at 
microtubule plus-ends. KIF1Cmut in green and microtubules are in magenta. KIF1Cmut 
– KIF1C mutant 
 
Both KIF1C patient mutant proteins, KIF1C-GFPP176L and KIF1C-GFPR169W 
showed plus-end accumulation along microtubules in the single molecule 
motility assays. The mutants are able to move processively but there are also 
diffusion events observed on the kymographs (Fig 5.11). KIF1C-GFPP176L 
behaved more like KIF1C wt but had a reduced velocity, whereas KIF1C-
GFPR169W showed a marked reduction in velocity and run length. 
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Figure 5.12: Velocity and Run distributions 
Histograms depict velocity and run length for KIF1C-GFP (blue), KIF1C-GFPP176L 
(orange) and KIF1C-GFPR169W (green). The mean values are indicated for each 
condition. V=velocity, d=run length. Representative kymographs show motility 
pattern. 
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5.2.4. Stepping behaviour of mutants 
 From the single molecule motility assays, it was clear that the mutants 
are active and can reach microtubule plus ends with a reduction in velocity 
and run length compared to KIF1C. Next, to probe how these mutants 
behaved under the load of the trap, optical trapping was carried out. 
Figure 5.13: Stepping traces of KIF1C wt and patient mutants 
Representative traces for KIF1C-GFP (blue), KIF1C-GFPP176L (orange) and KIF1C-
GFPR169W (green) under the load of the trap, plotted with force in piconewtons on Y-
axis and time in X-axis. The trap laser power for wt KIF1C was 400 mW and that for 
the mutants was 100 mW. 
 
The experiment was first performed at 400 mW laser power and KIF1C wt 
walked along microtubules but the patient mutants struggled to step along 
microtubules. Most of the beads were checked for the presence of a motor by 
letting it run with the trap off (zero load). This showed that the motor is indeed 
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bound to the bead but struggles to walk when the trap is switched on. Next, 
the laser was reduced to 100 mW and runs were observed for KIF1C-GFPP176L 
but it could only generate / step against forces up to 2 pN. KIF1C-GFPR169W 
was found to be bound to beads, when the trap was turned off the bead would 
move small distances but even with 100 mW laser power, this mutant was 
unable to walk along microtubules. 
 
5.3. Conclusion 
From these data, it was observed that the patient mutants are able to 
step along microtubules without any load but under load the mutant motor 
proteins struggle to take forward steps. Both pathogenic point mutations tested 
lie in the motor domain close to the microtubule interaction region and 
nucleotide hydrolysis site. Further experiments (ATPase and microtubule 
binding assays) are required to determine which aspect of function is defective 
and thereby understand how these single point mutations affect the motor 
proteins cargo transporting capacity under load. 
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CHAPTER 6 DISCUSSION 
 
6.1. Overview 
KIF1C is a kinesin-3 family motor protein that is involved in the transport 
of dense core vesicles in neurons (Lipka et al., 2016), α5b1 integrin transport 
to the cell protrusions and maintenance of cell tails in migrating cells (Theisen 
et al., 2012). In accordance with its function in long distance transport, 
mutations in KIF1C cause hereditary spastic paraplegia in humans (Dor et al., 
2014) (Caballero Oteyza et al., 2014). In this study, the various aspects of 
KIF1C regulation along with biochemical and mechanical properties of KIF1C 
and that of the patient mutants were addressed. 
 
6.2. KIF1C is an autoinhibited dimer 
 In order to transport cargo efficiently across long distances, kinesin 
motors need to step processively along microtubules. This is achieved by 
either functioning as dimers (Atherton et al., 2014) or in teams of multiple 
monomeric units (Oriola and Casademunt, 2013, Soppina and Verhey, 2014, 
Rogers et al., 2001). For kinesin-3 motor proteins, there are reports suggesting 
that both these modes are employed. Kinesin-3 family members such as 
KIF1A and KIF13A exist as monomers and are activated via dimerization 
(Soppina et al., 2014, Okada and Hirokawa, 1999, Tomishige et al., 2002). 
Whereas KIF13B and KIF16B are dimers with a tail block which is relieved 
upon cargo and/or adapter binding (Farkhondeh et al., 2015, Yamada et al., 
2007, Yoshimura et al., 2010, Hammond et al., 2009). We show here that 
KIF1C is a dimer in solution which has a slight shift in migration with the 
increase ionic strength suggesting that the motor might be in an equilibrium 
between extended and compact states. At physiological salt concentrations, 
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KIF1C adopts a compact conformation and transitions to an elongated state 
at higher ionic strength. This is similar to data reported for kinesin-1, which 
also undergoes a conformation change from a compact state in low ionic 
strength to an extended one in high ionic strength (Hackney et al., 1992). 
Using rotary shadow electron microscopy, the closed, folded state has been 
visualised for kinesin-1, while KIF1A appeared to be circular and compact with 
the tail close to the motor domain (Hirokawa, 1998, Hackney et al., 1992). 
From the hydrodynamic analysis, the calculated mass of KIF1C was 239 kD 
which is close to the predicted mass of a KIF1C for a dimeric motor (308 kD). 
This is consistent with earlier findings that in intact cells under transient 
overexpression, the motor protein dimerizes (Dorner et al., 1999).  
We employed cross-link mass spectrometry to validate the conformation state 
of KIF1C and found that the tail domain of KIF1C, specifically the third coiled 
coil (CC3) and FHA region made contacts with the second coiled coil (CC2) 
and the motor domain. This could mean that the tail region engages the motor 
heads and making them unavailable to bind microtubules. From kinesin-1 data 
it is known that the tail domain binds to the motor domain via the neck coiled 
coil region to keep it in a closed auto inhibitory state (Friedman and Vale, 1999, 
Stock et al., 1999, Coy et al., 1999). Similarly, reports for KIF16B also suggest 
that the second and third coiled coil make contacts with the motor domain to 
keep it in an autoinhibited state (Farkhondeh et al., 2015). We used deletion 
constructs of KIF1C lacking the third coiled coil region to determine if they are 
hyperactive. If the third coiled coil domain makes contacts with the motor 
domain then in the absence of this region, the motor should be hyperactive. 
The third coiled coil deletion construct was seen accumulating at all plus-ends 
without a rear bias and the cells observed lacked tails and were circular in 
shape, displaying a hyperactive phenotype and consistent with the cross-links 
identified by mass spectrometry. 
Taken together, the hydrodynamic analysis and cross-link mass spectrometry 
data suggest that KIF1C is in a compact conformation with the tail making 
contacts with the motor domain to keep it in a “closed” tail block state. 
However, the cross-link mass spectrometry experiments were performed only 
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once. Further experiments including repetitions of the cross-linking mass 
spectrometry and negative stain electron microscopy would help validate the 
results observed. The mutations generated were based solely on cross-link 
data. The exact interaction surfaces could be elsewhere. Co-crystallization 
studies with KIF1C motor domain and tail peptides would also help give insight 
into the interaction sites. FRAP (fluorescence recovery after photo bleaching) 
experiments in cells could help understand what happens when the 
hyperactive motor reaches the plus-end, it would be interesting to know if there 
is a bi-directional movement occurring or if the motors are stuck at the 
periphery since negative regulation via autoinhibition is not possible. However, 
it is known in KIF1C depleted cells the tail lifespan is reduced and there is loss 
of directional persistence (Theisen et al., 2012). In addition to this, in-vitro 
experiments such as purifying the deletion constructs and the coiled coil two 
mutant proteins and testing for their activity in a single molecule assay would 
also give insight into the activity of these constructs. 
 
6.3. PTPN21 FERM domain is an activator of KIF1C 
Figure 6.1: Mechanism of KIF1C activation 
KIF1C is in a autoinhibited tail-block state which gets activated upon binding to 
PTPN21 FERM domain and lands on microtubules. 
 
Activation of an autoinhibited motor by cargo interaction has been 
observed for many kinesins where the motor is activated either by binding to 
its cargo directly (Yamada et al., 2007) or by cargo adapter proteins that 
mediate motor activation and cargo loading (Wagner et al., 2009, Hsu et al., 
2011, Wu et al., 2016). PTPN21 FERM domain was identified to interact with 
KIF1C in a yeast two-hybrid screen (Dorner et al., 1998). Previous reports 
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generated in the lab (Bachmann et al, unpublished) indicated that PTPN21, a 
scaffolding phosphatase restores KIF1C mediated α5-integrin transport when 
overexpressed in KIF1C-depleted cells. This led to a hypothesis in which 
KIF1C is in a closed autoinhibited state, and the binding of PTPN21 relieves 
autoinhibition. However, there is also the possibility that PTPN21 FERM 
domain activates another kinesin motor in cells, such as KIF16B which is also 
known to interact with PTPN21 (Carlucci et al., 2010). 
Cross-linking mass spectrometry experiments with PTPN21 FERM domain 
and KIF1C revealed a lack of crosslinks between KIF1C coiled coil region and 
motor domain. Instead, there were new crosslinks identified between KIF1C 
and PTPN21 FERM domain. The absence of the crosslinks between the coiled 
coil regions and the motor domain supports the idea that maybe the binding 
of PTPN21 FERM domain has relieved KIF1C autoinhibition. Furthermore, 
single molecule motility assays with KIF1C and PTPN21 FERM domain 
showed a significant increase in the landing events and frequency of running 
motors observed. In addition, there was no difference in the frequency of 
running motors or landing rates between KIF1C and the FERM domain of 
Ezrin, suggesting that the effect is specific to the FERM domain of PTPN21 
and KIF1C.  
Thus, these data confirm that indeed PTPN21 FERM domain binds to KIF1C 
and relieves the inhibition of the tail region, thereby activating the motor. 
Further experiments are required to dissect the binding kinetics of KIF1C and 
PTPN21. It would be interesting to find out how many molecules of PTPN21 
are bound to KIF1C. It would also be insightful to determine if PTPN21 remains 
bound to KIF1C after activation and waits until cargo binds to dissociate since 
premature dissociation might promote autoinhibition. It is known that adapter 
proteins recruit motors to the cargo and steer them (Wagner et al., 2009, Hsu 
et al., 2011). It is not clear whether PTPN21 is a cargo adapter protein and 
how its phosphatase activity is regulated. Additionally, experiments such as 
single molecule motility assays with KIF16B and PTPN21 FERM domain 
would determine if the activation via PTPN21 FERM domain is specific to 
KIF1C or redundant across kinesin-3 family members. 
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KIF1C has also been implicated in bi-directional transport in which there can 
either be a tug of war where the motors of opposite polarity pull against each 
other and the strongest team wins (Amrute-Nayak and Bullock, 2012, Derr et 
al., 2012) or by a steric inhibition mechanism where one of the motor is active 
while the other is in a weakly bound state contributing to the processivity of 
the entire complex (Hancock, 2014). However, KIF1C depletion studies have 
shown that there is loss of movement in both directions (Schlager et al., 2010, 
Theisen et al., 2012). KIF1C and dynein both bind to adapter proteins such as 
BICDR-1 and HOOK3 (Schlager et al., 2010, Redwine et al., 2017, Schlager 
et al., 2014) which are proposed to facilitate cooperation between the two 
motors. KIF1C and BICDR-1 also bind Rab6A (Schlager et al., 2010, Lee et 
al., 2015) linking both dynein and KIF1C to cargo. Rab6A binds KIF1C at the 
tail region and at the motor domain. The binding of Rab6A to the motor domain 
disrupts the motor’s ability to walk along microtubules (Lee et al., 2015) while 
the consequence of the tail binding could promote cargo loading and 
activation. Rab6A could thereby act as a possible switch in bi-directional 
transport due to its ability to inhibit KIF1C. Other kinesin members such as 
KIF1A/UNC104 have also been reported to be involved in bi-directional 
transport (Tien et al., 2011). It has been hypothesized that the kinesin-3 
motors cooperate with dynein to regulate bi-directional transport of cargo 
(Bielska et al., 2014), however the mechanism of this has been poorly 
understood. Recent cryo electron microscopy reports suggest that in the 
presence of BICDR-1, one dynactin unit acts as a scaffold and recruits four 
dynein heavy chains which results in an increase in both speed and force 
exerted by the dynein complex compared with a single, dimeric dynein-
dynactin-BICD2 complex (Grotjahn et al., 2017, Urnavicius et al., 2017). 
However, it remains to be seen if PTPN21 binding results in an increase in 
KIF1C force generation and regulates switching of bidirectional transport 
complexes. 
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6.4. The Proline-rich region is required for KIF1C localisation in cells 
 In RPE cells, KIF1C accumulates at the tip of the tail and delivers α5b1 
integrin receptors that are required for the maturation of trailing adhesion and 
maintenance of cell tails (Theisen et al., 2012). To address how KIF1C is 
retained at the tip of the tail, KIF1C truncation constructs were used in co-
localization studies with full-length KIF1C which revealed that the proline-rich 
region in the C-terminus was necessary for efficient localisation of KIF1C at 
the front as well as rear, although it accumulates to a greater extent at the rear 
of the cell. Proline-rich regions are known to mediate protein-protein 
interactions (Williamson, 1994) and from the co-localization studies it is 
evident that the this region contributes to localization of KIF1C. The different 
proteins known to bind KIF1C via the proline-rich region are BICDR-1, 14-3-3 
and Rab6 proteins. However, the construct KIF1C1-1043GFP lacks the 14-3-3, 
Rab6 binding sites and part of BICDR-1 binding site (811-1090 amino acids). 
But the region that was found to be required for KIF1C localization was 
between 950-1043 amino acids, which suggests that this region possibly 
interacts with yet another unknown protein or it could be possible that any of 
the above-mentioned tail interacting proteins are involved in this interaction 
since the mapping sites are in close proximity. In future, experiments can be 
carried out using chimeric kinesin construct with the kinesin-1 head and KIF1C 
tail and vice versa. Kinesin-1 does not normally localize to the tail, if the 
chimeric kinesin-1 head - KIF1C tail construct now localizes to the tail and the 
vice versa if the KIF1C head - kinesin-1tail does not localize to the tail anymore 
it would validate that indeed it’s the proline-rich region that mediates tail 
localization. Further to this, pull-down experiments in cell extracts with the 
proline-rich region could identify potential interactors that bind to this region 
and possibly anchor the motor protein at the tail and probe the mechanism by 
which the proline-rich region mediates KIF1C tail localization. 
From the co-localization studies using KIF1C constructs it also became clear 
that the fourth coiled coil region (CC4) was important for dimerization of 
KIF1C. Previously it has been shown using yeast two-hybrid assay that the 
CC4 is sufficient to drive dimerization (Dorner et al., 1999). Here, it was 
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observed that the constructs lacking CC4 domain did not show any co-
localization with FL-KIF1C, but the other constructs which included the CC4 
domains showed co-localization with FL-KIF1C to varying extents suggesting 
that CC4 is important for dimerization. 
 
6.5. 14-3-3 proteins negatively regulate KIF1C activity 
Figure 6.2: Negative regulation by 14-3-3 proteins 
In cells, binding of 14-3-3 proteins negatively regulate KIF1C activity. This could be 
either by stabilizing the autoinhibition state or by reducing the microtubule affinity of 
the motor resulting in unbinding from the MT. 
 
14-3-3 proteins are known to bind phosphoserine and/or 
phosphothreonine proteins and regulate their activity (Tzivion et al., 2001). 
There are seven mammalian isoforms and they exist as dimers (Fu et al., 
2000). It is known that the phosphorylation of Ser1092 in KIF1C is required for 
14-3-3 binding and mutating the Ser1092 to Ala results in disruption of 14-3-3 
binding to KIF1C (Dorner et al., 1999). Here, the functional consequence of 
14-3-3 binding was addressed by disrupting the interaction site using 
mutagenesis. 
In cells, it was observed that the S1092A mutant accumulated at a higher level 
at the tail and front in comparison to wt KIF1C. This means that in the absence 
of 14-3-3 protein binding, there is higher accumulation observed in cells. 
These results suggest that 14-3-3 proteins negatively regulate KIF1C. It is 
known for KIF13B, a kinesin-3 family member that 14-3-3β binding promotes 
the autoinhibited state (Yoshimura et al., 2010). Similar reports for kinesin-1 
and kinesin-6 also suggest the same (Ichimura et al., 2002, Geiger et al., 2014, 
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Douglas et al., 2010, Joseph et al., 2012) proposing that negative regulation 
by 14-3-3 proteins is a common mode to “turn off” the motor and it could 
potentially act as a switch and/or signal for other adapter proteins and/or cargo 
to bind and drive transport. The S1092E mutant also accumulated to the same 
extent as that of S1092A mutant. Literature suggests that the amino acid 
residues glutamate and aspartate do not serve as good phosphomimetic 
residues with respect to 14-3-3 binding to target proteins (Johnson et al., 
2010), which explains why non-phosphorylatable and phosphomimicking 
mutations result in a similar phenotype. Further experiments in vitro such as 
microtubule binding assays and single molecule motility assays with purified 
14-3-3 proteins and KIF1C would shed light on the mechanism of 14-3-3 
regulation. It would be of interest to determine if the binding of 14-3-3 proteins 
to KIF1C reduces the affinity of the motor to the microtubules or it would 
promote the interaction between tail and the motor domain to keep the protein 
in an autoinhibited state as in case of KIF13B. It would also be interesting to 
identify the kinase that phosphorylates KIF1C at Ser1092 and other potential 
sites and to determine when and where KIF1C is phosphorylated. Is the kinase 
present in the vicinity of KIF1C? If so, what is the upstream signalling pathway 
that determines the phosphorylation status of KIF1C remains to be addressed. 
 
6.6. Force generation of KIF1C and HSP causing patient mutants 
 The single molecule mechanics of KIF1C gave insight into the 
mechanical properties of the motor protein. The K-loop is a feature that is 
specific to kinesin-3 members. Previously it has been shown that this stretch 
of positively charged lysine residues enhances microtubule binding (Rogers 
et al., 2001). Since KIF1C is implicated in long distance cargo transport in 
neurons (Lipka et al., 2016) and disease causing mutations (Caballero Oteyza 
et al., 2014), it was essential to elucidate these properties. KIF1C was found 
to walk processively along microtubules under the load of the trap. The step-
size of KIF1C was found to be 7.4 nm which is similar to the step-size of 
kinesin-1 motor protein (8 nm), which corresponds to the distance between 
microtubule heterodimeric subunits (Svoboda et al., 1993). The stall force for 
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KIF1C was found to be ~5.5 pN at which the net forward and backward 
movement is equal. From literature, it is known that dynein has a stall force of 
around 0.5-1.5 pN (Torisawa et al., 2014, Rai et al., 2013) and kinesin-1 can 
stall to about 6 pN (Visscher et al., 1999) which is similar to the stall force of 
KIF1C measured here, suggesting that KIF1C can also generate opposing 
forces required in bi-directional transport. More recently it has been shown 
that the DDR complex (dynein, dynactin, BICDR-1) can generate large 
resistive forces of upto 6.5 pN and can now compete with kinesin motors in a 
tug-of-war scenario (Urnavicius et al., 2017). 
Hereditary spastic paraplegia (HSP) presents with stiffness of the lower limbs 
and axon degeneration due to defects in various cellular processes one being 
cargo transport (Blackstone, 2012). It is thought that the efficiency of the motor 
transport is affected since the mutated motor is either slower or has reduced 
microtubule affinity (Ebbing et al., 2008). The HSP causing patient mutants in 
KIF1C that were tested here were able to reach the plus-ends of microtubules 
with no cargo or load attached. However, they struggled to walk along 
microtubules under the load of the trap even at low laser power (100mW). This 
may be due the mutations being present in the well conserved microtubule 
binding and ATP hydrolysis regions. This in turn might lead to the inability of 
the motor to generate forces and take forward steps in the presence of the 
load/cargo attached to the tail. Reports for kinesin-1 and KIF1A suggest that 
mutation in the motor domain result in lack of stimulation of the motor ATPase 
and reduced microtubule affinity (Reid et al., 2002, Erlich et al., 2011, Crimella 
et al., 2012, Dion et al., 2009). However, the mechanism of these HSP causing 
mutations remains unclear. 
 
6.7. Conclusion 
Kinesin-3 family of motor proteins are important neuronal long distance 
cargo transporters. They are particularly suited for long haul transport since 
they are highly processive. Hence, it is essential to understand the mode of 
regulation as well as their mechanism of motor activation since mutations in 
these motor proteins cause neurological disorders and motor impairments in 
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humans. However, it has been unclear as to what the mode of activation for 
this family of motors is (Siddiqui and Straube, 2017). 
In this study, we determine the mechanism of activation and elucidate the 
oligomeric status of KIF1C. The study presented here is consistent with a 
model in which KIF1C is a dimer which is autoinhibited by its tail region. The 
PTPN21-FERM domain activates KIF1C. While in cells, the proline-rich region 
is necessary for proper localisation and the binding of 14-3-3 proteins 
negatively regulates KIF1C activity. Further to this, the HSP causing disease 
mutations that were tested, walked along microtubules and reached plus-ends 
in the absence of a cargo but failed to do the same under load of the trap. 
The study presented here has shed light on the mechanism of regulation of 
KIF1C. However, further experiments are required to better understand if the 
FERM domain of PTPN21 stabilises the open conformation and since the 
FERM domain also interacts with KIF16B which is another kinesin-3, Could 
this be a general mode of activation for kinesin-3 family remains to be seen. 
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